<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <atom:link rel="self" type="application/rss+xml" href="https://escholarship.org/uc/ucideptmed_oapdeposits/rss"/>
    <ttl>720</ttl>
    <title>Recent ucideptmed_oapdeposits items</title>
    <link>https://escholarship.org/uc/ucideptmed_oapdeposits/rss</link>
    <description>Recent eScholarship items from Open Access Policy Deposits</description>
    <pubDate>Fri, 18 Sep 2026 06:46:19 +0000</pubDate>
    <item>
      <title>Peripheral cannabinoid-1 receptor antagonists in clinical development: therapeutic potential for the management of obesity and related metabolic disorders</title>
      <link>https://escholarship.org/uc/item/8zr9b7pj</link>
      <description>INTRODUCTION: Obesity is a chronic metabolic disease associated with insulin resistance, cardiometabolic complications, and increased mortality. Limitations of existing therapies have driven interests in alternative biological targets, including the endocannabinoid system and the cannabinoid-1 receptor (CB1R) signaling pathway.
AREAS COVERED: This review examines the rationale for targeting peripheral CB1R signaling and summarizes preclinical and clinical evidence supporting peripherally restricted CB1R antagonists and inverse agonists for obesity and related metabolic disorders. The metabolic effects of CB1R blockade in peripheral tissues are discussed, as well as distinctions between central and peripheral CB1R inhibition. The article also reviews the current development landscape of CB1R-targeted compounds, including agents evaluated in early-phase clinical trials. Literature was identified through PubMed, Embase, and Scopus, supplemented by ClinicalTrials.gov.
EXPERT OPINION:...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8zr9b7pj</guid>
      <pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Talebloo, Jonanne</name>
      </author>
      <author>
        <name>Chawla, Esha</name>
      </author>
      <author>
        <name>Shahamati, Donya</name>
      </author>
      <author>
        <name>Shiv, Swas</name>
      </author>
      <author>
        <name>Gadde, Kishore M</name>
      </author>
    </item>
    <item>
      <title>How does prior infection and vaccination relate to the risk of incident SARS-CoV-2 infection/reinfection? A prospective cohort study among nine clinical sites in the USA, February 2021 to January 2023</title>
      <link>https://escholarship.org/uc/item/89q1d66t</link>
      <description>OBJECTIVE: To estimate the relative effectiveness of vaccination (0, 1, 2, ≥3 doses) and prior infection, in combination, on risk of SARS-CoV-2 infection/reinfection.
DESIGN: Prospective cohort study.
PARTICIPANTS: We recruited participants for the Aegis Study from nine clinics across five US states. Participants must have been 18 years or older, had a history of a positive PCR for SARS-CoV-2, SARS-CoV-2 antigen or antibody test for SARS-CoV-2 with documentation or had no suspected or documented prior SARS-CoV-2 infection, intended to remain in study area for the next 12 months, and had elevated risk of future SARS-CoV-2 exposure. Exclusion criteria included acute illness, contraindication to phlebotomy, use of immunosuppressants or receipt of systemic immunoglobulins.
METHODS: We used extended Cox regression with robust standard errors to estimate the association between time-varying number of vaccine doses and baseline prior infection on risk of infection/reinfection among a...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/89q1d66t</guid>
      <pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Judge, Ashley</name>
      </author>
      <author>
        <name>Beidelman, Erika T</name>
      </author>
      <author>
        <name>Allison, David B</name>
      </author>
      <author>
        <name>Dickinson, Stephanie</name>
      </author>
      <author>
        <name>Gadde, Kishore M</name>
      </author>
      <author>
        <name>Arroyo, Lilian Golzarri</name>
      </author>
      <author>
        <name>Ioannidis, John P</name>
      </author>
      <author>
        <name>Macagno, Anna LM</name>
      </author>
      <author>
        <name>Macy, Jonathan T</name>
      </author>
      <author>
        <name>Maki, Kevin C</name>
      </author>
      <author>
        <name>Perlman, Stanley</name>
      </author>
      <author>
        <name>Ricciardi, Michael J</name>
      </author>
      <author>
        <name>Rosenberg, Molly</name>
      </author>
      <author>
        <name>Ludema, Christina</name>
      </author>
    </item>
    <item>
      <title>Coronary Artery Calcium and Cognitive Decline in the Diabetes Prevention Program Outcomes Study</title>
      <link>https://escholarship.org/uc/item/7cf7w9gt</link>
      <description>Background Our aim was to investigate the association of coronary artery calcium (CAC) with cognitive function in adults with impaired glucose tolerance or type 2 diabetes. Methods and Results The Diabetes Prevention Program was a randomized controlled trial comparing an intensive lifestyle intervention, metformin, or placebo for prevention of type 2 diabetes among patients with prediabetes. After 3 years, intensive lifestyle intervention and placebo were stopped, the metformin arm was unmasked, and participants continued in the DPPOS (Diabetes Prevention Program Outcomes Study). Approximately 14 years after randomization (Y14), CAC (Agatston score) was assessed with computed tomography, and cognitive performance was assessed with the Spanish English Verbal Learning Test (SEVLT) and Digit Symbol Substitution Test. SEVLT and Digit Symbol Substitution Test were reassessed 5 years later (Y19) along with the Modified Mini-Mental State Exam. We examined cross-sectional and longitudinal...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7cf7w9gt</guid>
      <pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Gadde, Kishore M</name>
      </author>
      <author>
        <name>Yin, Xiaoyan</name>
      </author>
      <author>
        <name>Goldberg, Ronald B</name>
      </author>
      <author>
        <name>Orchard, Trevor J</name>
      </author>
      <author>
        <name>Schlögl, Mathias</name>
      </author>
      <author>
        <name>Dabelea, Dana</name>
      </author>
      <author>
        <name>Ibebuogu, Uzoma N</name>
      </author>
      <author>
        <name>Watson, Karol E</name>
      </author>
      <author>
        <name>Pi‐Sunyer, F Xavier</name>
      </author>
      <author>
        <name>Crandall, Jill P</name>
      </author>
      <author>
        <name>Temprosa, Marinella</name>
      </author>
      <author>
        <name>Luchsinger, José A</name>
      </author>
      <author>
        <name>Group, the Diabetes Prevention Program Research</name>
      </author>
    </item>
    <item>
      <title>Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty Delphi</title>
      <link>https://escholarship.org/uc/item/2620838d</link>
      <description>Patients with cirrhosis have abnormal coagulation indices such as a high international normalized ratio and low platelet count, but these do not correlate well with periprocedural bleeding risk. We sought to develop a consensus among the multiple stakeholders in cirrhosis care to inform process measures that can help improve the quality of the periprocedural management of coagulopathy in cirrhosis. We identified candidate process measures for periprocedural coagulopathy management in multiple contexts relating to the performance of paracentesis and upper endoscopy. An 11-member panel with content expertise was convened. It included nominees from professional societies for interventional radiology, transfusion medicine, and anesthesia as well as representatives from hematology, emergency medicine, transplant surgery, and community practice. Each measure was evaluated for agreement using a modified Delphi approach (3 rounds of rating) to define the final set of measures. Out of...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2620838d</guid>
      <pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Tapper, Elliot B</name>
      </author>
      <author>
        <name>Warner, Matthew A</name>
      </author>
      <author>
        <name>Shah, Rajesh P</name>
      </author>
      <author>
        <name>Emamaullee, Juliet</name>
      </author>
      <author>
        <name>Dunbar, Nancy M</name>
      </author>
      <author>
        <name>Sholzberg, Michelle</name>
      </author>
      <author>
        <name>Poston, Jacqueline N</name>
      </author>
      <author>
        <name>Soto, Robin J</name>
      </author>
      <author>
        <name>Sarwar, Ammar</name>
      </author>
      <author>
        <name>Pillai, Anjana</name>
      </author>
      <author>
        <name>Reyner, Karina</name>
      </author>
      <author>
        <name>Mehta, Shivang</name>
      </author>
      <author>
        <name>Ghabril, Marwan</name>
      </author>
      <author>
        <name>Morgan, Timothy R</name>
      </author>
      <author>
        <name>Caldwell, Stephen</name>
      </author>
    </item>
    <item>
      <title>Editorial: New insights into stellate ganglion blockade in basic and clinical studies</title>
      <link>https://escholarship.org/uc/item/9vm26912</link>
      <description>Editorial: New insights into stellate ganglion blockade in basic and clinical studies</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9vm26912</guid>
      <pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guo, Zhi-Ling</name>
        <uri>https://orcid.org/0000-0001-7817-6872</uri>
      </author>
      <author>
        <name>Reist, Christopher</name>
      </author>
      <author>
        <name>Malik, Shaista</name>
      </author>
    </item>
    <item>
      <title>Fos‐CreER Based Genetic Mapping of Forebrain Regions Activated by Acupuncture</title>
      <link>https://escholarship.org/uc/item/94f2x1k5</link>
      <description>Acupuncture is an important practice used in traditional Chinese medicine (TCM), and it generates therapeutic effects through the insertion of thin needles through the skin at specific acupoint(s) in the body to stimulate sensory nerves. Many of the acupoints have multiple therapeutic indications. Using rodent models, we have found that manual acupuncture (MA) at the Neiguan (P6) acupoint overlying median nerve inhibits excitatory cardiovascular reflex responses through its influence on specific regions involving in the regulation of autonomic nervous system in the brain stem. However, in TCM, it is also the acupoint for treating nausea and headaches. It is largely unknown whether MA at this acupoint activates neurons in the brain regions beyond the brain stem. To further understand neural mechanisms underlying acupuncture effects, in this study, we map P6 specific neural activation by MA in the forebrain using a Fos‐CreER based mouse genetic strategy. Identification of c‐Fos...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/94f2x1k5</guid>
      <pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guo, Zhi‐Ling</name>
        <uri>https://orcid.org/0000-0001-7817-6872</uri>
      </author>
      <author>
        <name>Lin, Xiaoxiao</name>
      </author>
      <author>
        <name>Samaniego, Tracy</name>
      </author>
      <author>
        <name>Isreb, Alexander</name>
      </author>
      <author>
        <name>Cao, Stacey</name>
      </author>
      <author>
        <name>Malik, Shaista</name>
      </author>
      <author>
        <name>Xu, Xiangmin</name>
      </author>
    </item>
    <item>
      <title>Role of Dietary Antioxidants in the Preservation of Vascular Function and the Modulation of Health and Disease.</title>
      <link>https://escholarship.org/uc/item/9gp161sp</link>
      <description>In vascular diseases, including hypertension and atherosclerosis, vascular endothelial dysfunction (VED) occurs secondary to altered function of endothelial nitric oxide synthase (eNOS). A novel redox regulated pathway was identified through which eNOS is uncoupled due to &lt;i&gt;S&lt;/i&gt;-glutathionylation of critical cysteine residues, resulting in superoxide free radical formation instead of the vasodilator molecule, nitric oxide. In addition, the redox sensitive cofactor tetrahydrobiopterin, BH&lt;sub&gt;4&lt;/sub&gt;, is also essential for eNOS coupling. Antioxidants, either individually or combined, can modulate eNOS uncoupling by scavenging free radicals or impairing specific radical generating pathways, thus preventing oxidative stress and ameliorating VED. Epidemiological evidence and dietary guidelines suggest that diets high in antioxidants, or antioxidant supplementation, could preserve vascular health and prevent cardiovascular diseases (CVDs). Therefore, the purpose of this review is...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9gp161sp</guid>
      <pubDate>Mon, 24 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Varadharaj, Saradhadevi</name>
      </author>
      <author>
        <name>Kelly, Owen</name>
      </author>
      <author>
        <name>Khayat, Rami</name>
      </author>
      <author>
        <name>Kumar, Purnima</name>
      </author>
      <author>
        <name>Ahmed, Naseer</name>
      </author>
      <author>
        <name>Zweier, Jay</name>
      </author>
    </item>
    <item>
      <title>Polysomnography validation of SANSA to detect obstructive sleep apnea.</title>
      <link>https://escholarship.org/uc/item/3w4339qh</link>
      <description>&lt;h4&gt;Study objectives&lt;/h4&gt;Evaluate the performance of a novel home sleep apnea test with embedded ECG (SANSA, Huxley Medical, Inc.) in the diagnosis of obstructive sleep apnea (OSA).&lt;h4&gt;Methods&lt;/h4&gt;This prospective multicenter validation study included 340 participants who underwent simultaneous polysomnography (PSG) and SANSA recordings across 7 clinical sites. Participants were diverse across age, sex, race, skin tone, and body mass index. Diagnostic performance was assessed with the apnea-hypopnea index (AHI) using both Rule 1A and Rule 1B across standard cutoffs for mild, moderate, or severe (≥5 events/h), moderate-to-severe (≥15 events/h), and severe (≥30 events/h) OSA. The agreement for AHI and total sleep time (TST) between SANSA and consensus PSG scores from three independent scorers was evaluated using Pearsons correlation and Bland-Altman analysis. Sensitivity and specificity were calculated at each OSA severity level. Performance of participating site PSG scores were...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3w4339qh</guid>
      <pubDate>Mon, 24 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Goldstein, Cathy</name>
      </author>
      <author>
        <name>Ghanbari, Hamid</name>
      </author>
      <author>
        <name>Sharma, Surina</name>
      </author>
      <author>
        <name>Collop, Nancy</name>
      </author>
      <author>
        <name>Namen, Andrew</name>
      </author>
      <author>
        <name>Kirsch, Douglas</name>
      </author>
      <author>
        <name>Drucker, Michael</name>
      </author>
      <author>
        <name>Khayat, Rami</name>
      </author>
      <author>
        <name>Pollock, Mark</name>
      </author>
      <author>
        <name>Torstrick, Brennan</name>
      </author>
      <author>
        <name>Walsh, Colleen</name>
      </author>
      <author>
        <name>Herreshoff, Emily</name>
      </author>
      <author>
        <name>Frankel, David</name>
      </author>
      <author>
        <name>Rosen, Ilene</name>
      </author>
    </item>
    <item>
      <title>Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure.</title>
      <link>https://escholarship.org/uc/item/2wn07951</link>
      <description>&lt;h4&gt;Aims&lt;/h4&gt;The presence of central sleep apnoea (CSA) is associated with poor prognosis in patients with heart failure (HF). The aim of this analysis was to evaluate if using phrenic nerve stimulation to treat CSA in patients with CSA and HF was associated with changes in HF-specific metrics.&lt;h4&gt;Methods and results&lt;/h4&gt;All patients randomized in the remedē System Pivotal Trial and identified at baseline with HF were included (n = 96). Effectiveness data from treatment and former control groups were pooled based on months since therapy activation. Changes from baseline to 6 and 12 months in sleep metrics, Epworth Sleepiness Scale, patient global assessment health-related quality of life, Minnesota Living with Heart Failure Questionnaire (MLHFQ), and echocardiographic parameters are reported. HF hospitalization, cardiovascular death, and the composite of HF hospitalization or cardiovascular death within 6 months are reported by the original randomized group assignment for safety...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2wn07951</guid>
      <pubDate>Mon, 24 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Costanzo, Maria</name>
      </author>
      <author>
        <name>Ponikowski, Piotr</name>
      </author>
      <author>
        <name>Coats, Andrew</name>
      </author>
      <author>
        <name>Javaheri, Shahrokh</name>
      </author>
      <author>
        <name>Augostini, Ralph</name>
      </author>
      <author>
        <name>Goldberg, Lee</name>
      </author>
      <author>
        <name>Holcomb, Richard</name>
      </author>
      <author>
        <name>Kao, Andrew</name>
      </author>
      <author>
        <name>Khayat, Rami</name>
      </author>
      <author>
        <name>Oldenburg, Olaf</name>
      </author>
      <author>
        <name>Stellbrink, Christoph</name>
      </author>
      <author>
        <name>McKane, Scott</name>
      </author>
      <author>
        <name>Abraham, William</name>
      </author>
    </item>
    <item>
      <title>Adaptive servoventilation in clinical practice: beyond SERVE-HF?</title>
      <link>https://escholarship.org/uc/item/2f22d1j7</link>
      <description>Adaptive servoventilation (ASV) has proven effective at suppressing breathing disturbances during sleep, improving quality of life and cardiac surrogate parameters. Since the publication of the SERVE-HF-trial, ASV became restricted. The purpose of this study was to evaluate the clinical relevance of the SERVE-HF inclusion criteria in real life and estimate the portion of patients with these criteria with or without risk factors who are undergoing ASV treatment. We performed a retrospective study of all patients who were treated with ASV in a university-affiliated sleep laboratory. We reviewed the history of cardiovascular diseases, echocardiographic measurements of left ventricular ejection fraction (LVEF) and polysomnography. From 1998 to 2015, 293 patients received ASV, of which 255 (87.0%) had cardiovascular diseases and 118 (40.3%) had HF. Among those with HF, the LVEF was ≤45% in 47 patients (16.0%). Only 12 patients (4.1%) had LVEF &amp;lt;30%. The SERVE-HF inclusion criteria...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2f22d1j7</guid>
      <pubDate>Mon, 24 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Randerath, Winfried</name>
      </author>
      <author>
        <name>Schumann, Katja</name>
      </author>
      <author>
        <name>Treml, Marcel</name>
      </author>
      <author>
        <name>Herkenrath, Simon</name>
      </author>
      <author>
        <name>Castrogiovanni, Alessandra</name>
      </author>
      <author>
        <name>Javaheri, Shahrokh</name>
      </author>
      <author>
        <name>Khayat, Rami</name>
      </author>
    </item>
    <item>
      <title>Automatic activation of neurostimulation for central sleep apnea results in high nightly usage.</title>
      <link>https://escholarship.org/uc/item/0pm25969</link>
      <description>PURPOSE: Adherence with mask-based therapies remains a significant challenge for patients with sleep-disordered breathing. Transvenous phrenic nerve stimulation (TPNS) to treat central sleep apnea (CSA) in adults offers a novel, automated approach to enhance nightly adherence by initiating therapy automatically based on patient-specific programmed conditions such as sleep schedule, activity, and body position. This retrospective analysis aims to determine the adherence achieved with TPNS’s automated activation approach. METHODS: Device data from 131 remedē®System Pivotal Trial participants were analyzed to calculate median daily hours of therapy within 14 days prior to visits. Therapy duration was defined as time when all conditions to activate therapy were met between the first-time therapy on to last time off during the night. RESULTS: Median [Q1-Q3] nightly therapy duration at 6, 12, 18, and 24 months was 5.9 [4.9–6.6], 5.7 [5.0-6.8], 6.0 [5.3–6.8], and 5.9 [4.9–6.5] hours,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0pm25969</guid>
      <pubDate>Mon, 24 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Khayat, Rami</name>
      </author>
      <author>
        <name>Khan, Meena</name>
      </author>
      <author>
        <name>Morgenthaler, Timothy</name>
      </author>
      <author>
        <name>McKane, Scott</name>
      </author>
      <author>
        <name>Germany, Robin</name>
      </author>
      <author>
        <name>Costanzo, Maria</name>
      </author>
    </item>
    <item>
      <title>A mixed methods evaluation of 99DOTS digital adherence technology uptake among adolescents treated for pulmonary tuberculosis in Uganda</title>
      <link>https://escholarship.org/uc/item/5q14t98s</link>
      <description>Background: Adolescents are at risk of poor adherence to tuberculosis (TB) treatment and subsequently worse treatment outcomes. Digital adherence technologies, including the mobile phone-based 99DOTS platform, can support TB treatment, but there is limited data on their use among adolescents. We evaluated factors associated with uptake of 99DOTS among adolescents with TB.
Methods: We conducted an explanatory sequential mixed methods study that utilized quantitative data from adolescents collected at 30 health facilities in Uganda, in-depth and key informant interviews with adolescents diagnosed for TB who were offered 99DOTS, and healthcare workers at participating facilities. Findings were further mapped onto the Capability, Opportunity, Motivation, and Behavior model.
Results: Overall, 299/410 (73 %) adolescents were enrolled in 99DOTS. Older adolescents 15-19 years old were more likely to enroll in 99DOTS than younger adolescents 10-14 years [aPR= 1.88, 95 % CI: (1.54-2.33)]....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5q14t98s</guid>
      <pubDate>Thu, 13 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Wambi, P</name>
      </author>
      <author>
        <name>West, SN</name>
      </author>
      <author>
        <name>Nabugoomu, J</name>
      </author>
      <author>
        <name>Kityamuwesi, A</name>
      </author>
      <author>
        <name>Crowder, R</name>
      </author>
      <author>
        <name>Kunihira, L</name>
      </author>
      <author>
        <name>Wobudeya, E</name>
      </author>
      <author>
        <name>Cattamanchi, A</name>
        <uri>https://orcid.org/0000-0002-6553-2601</uri>
      </author>
      <author>
        <name>Jaganath, D</name>
      </author>
      <author>
        <name>Katamba, A</name>
      </author>
    </item>
    <item>
      <title>A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia</title>
      <link>https://escholarship.org/uc/item/9nt6q31j</link>
      <description>A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9nt6q31j</guid>
      <pubDate>Thu, 30 Jul 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Strati, Paolo</name>
      </author>
      <author>
        <name>Tong, Wei-Gang</name>
      </author>
      <author>
        <name>Vitale, Candida</name>
      </author>
      <author>
        <name>Wierda, William G</name>
      </author>
      <author>
        <name>O’Brien, Susan</name>
      </author>
      <author>
        <name>Brown, Jennifer R</name>
      </author>
      <author>
        <name>Weng, Wen-Kai</name>
      </author>
      <author>
        <name>Kipps, Thomas</name>
        <uri>https://orcid.org/0000-0002-0064-4549</uri>
      </author>
      <author>
        <name>Keating, Michael J</name>
      </author>
      <author>
        <name>Ferrajoli, Alessandra</name>
      </author>
    </item>
    <item>
      <title>Microfluidic Precision Engineered Artificial GARP Presenting Cells for Regulatory T-Cell Induction</title>
      <link>https://escholarship.org/uc/item/8bc797fw</link>
      <description>PurposeThe incidence of autoimmune diseases has increased in Western societies, highlighting the need for novel treatment strategies. Current therapies, including biologics, are limited by high costs, potential adverse effects, and often lack specificity and long-term efficacy. Regulatory T cells (Tregs) are crucial for maintaining immune tolerance and represent a promising target for autoimmune disease therapies. However, current methods for inducing Tregs, such as in vitro cytokine combinations and in vivo antigen-specific approaches, face challenges in stability and effectiveness. This research aims to develop an innovative artificial cell platform to enhance Treg induction for autoimmune disease treatment.MethodsThis study developed artificial GARP-presenting cells (aGPCs), an innovative artificial cell platform designed to mimic natural cellular functions and enhance Treg induction. We evaluated aGPC efficacy in inducing Tregs both in vitro and in vivo, comparing results...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8bc797fw</guid>
      <pubDate>Thu, 30 Jul 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Yi, Hsiu-Ping</name>
      </author>
      <author>
        <name>Agrawal, Sudhanshu</name>
      </author>
      <author>
        <name>Tam, Giovanni Hau Lai</name>
      </author>
      <author>
        <name>Fong, Nicole</name>
      </author>
      <author>
        <name>Chen, Jui-Yi</name>
      </author>
      <author>
        <name>Agrawal, Anshu</name>
        <uri>https://orcid.org/0000-0003-4898-9615</uri>
      </author>
      <author>
        <name>Lee, Abraham P</name>
        <uri>https://orcid.org/0000-0001-8378-6616</uri>
      </author>
    </item>
    <item>
      <title>Adolescent exposure to Δ9-tetrahydrocannabinol impairs testicular function in young adult male mice</title>
      <link>https://escholarship.org/uc/item/23f964sw</link>
      <description>Cannabis use typically starts in early to mid-adolescence. Δ9-tetrahydrocannabinol (THC), the primary psychoactive component of cannabis, targets cannabinoid receptors (CBRs) to exert its pharmacological effects. Expression of CBRs has been observed in human and rodent testes, but their potential role in the control of reproductive function remains unclear. We aimed to elucidate how THC exposure during adolescence or young adulthood affects the reproductive health of males. C57BL/6N male mice were given THC (5 mg/kg) or vehicle, once daily by intraperitoneal injection from postnatal day (PND) 30 to PND 43 (adolescent exposure) or PND 70 to PND 83 (adult exposure), and testes were harvested at PND 70 and PND 110, respectively. Results showed that CBRs (CB1R and CB2R) and enzymes that biosynthesize or inactivate the endocannabinoids anandamide-N-acylphosphatidylethanolamine phospholipase D or fatty acid amide hydrolase, respectively-are expressed in the mouse testis. THC exposure...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/23f964sw</guid>
      <pubDate>Thu, 30 Jul 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Lim, Jinhwan</name>
      </author>
      <author>
        <name>Quach, Caitlin</name>
      </author>
      <author>
        <name>Nguyen, Julie</name>
      </author>
      <author>
        <name>Rizk, Andrew</name>
      </author>
      <author>
        <name>Getze, Samantha</name>
      </author>
      <author>
        <name>Jung, Kwang-Mook</name>
      </author>
      <author>
        <name>Mahler, Stephen V</name>
        <uri>https://orcid.org/0000-0002-8698-0905</uri>
      </author>
      <author>
        <name>Piomelli, Daniele</name>
      </author>
      <author>
        <name>Luderer, Ulrike</name>
        <uri>https://orcid.org/0000-0002-8639-1326</uri>
      </author>
    </item>
    <item>
      <title>Neuropsychiatric symptom and biomarker changes with electroacupuncture in adolescent and young adult (AYA) cancer survivors: Results from a randomized controlled trial.</title>
      <link>https://escholarship.org/uc/item/1qd061qg</link>
      <description>10054   Background: Electroacupuncture (EA) shows promise for managing neuropsychiatric symptoms, yet its role in adolescent and young adult (AYA) cancer survivors remains unclear. We conducted a randomized, controlled, patient- and assessor-blinded pilot trial comparing two EA regimens to evaluate effects on neuropsychiatric symptoms and associated biomarkers in AYA cancer survivors (ClinicalTrials.gov: NCT05283577). Methods: AYA cancer survivors aged 16–39 years who self-reported cognitive impairment, fatigue, insomnia, or psychological distress were randomized (1:1) to receive ten weekly EA sessions targeting either neuropsychiatric-specific acupoints (nEA) or non-neuropsychiatric-specific acupoints (sham EA; sEA). Blood collection, neurocognitive testing (CANTAB), and patient-reported outcomes (FACT-Cog, MFSI-SF, EORTC QLQ-C30) were obtained at four timepoints. Sixteen plasma cytokines were measured using ProcartaPlex immunoassays, and brain-derived neurotrophic factor (BDNF)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1qd061qg</guid>
      <pubDate>Thu, 30 Jul 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Chan, Alexandre</name>
        <uri>https://orcid.org/0000-0003-4391-4219</uri>
      </author>
      <author>
        <name>Heshmatipour, Matthew</name>
      </author>
      <author>
        <name>Ng, Ding Quan</name>
      </author>
      <author>
        <name>Trudeau, Julia</name>
      </author>
      <author>
        <name>Acharya, Munjal</name>
        <uri>https://orcid.org/0000-0002-7767-5642</uri>
      </author>
      <author>
        <name>Agrawal, Anshu</name>
        <uri>https://orcid.org/0000-0003-4898-9615</uri>
      </author>
      <author>
        <name>Malik, Shaista</name>
      </author>
      <author>
        <name>Xie, Lifang</name>
      </author>
      <author>
        <name>Chang, Yae</name>
      </author>
      <author>
        <name>Zabokrtsky, Keri</name>
      </author>
      <author>
        <name>Yun, Christine</name>
      </author>
      <author>
        <name>Lin, Carol Hwang</name>
      </author>
      <author>
        <name>Morales, Sonia</name>
      </author>
      <author>
        <name>Frediani, Jamie</name>
      </author>
      <author>
        <name>Torno, Lilibeth Ramilo</name>
      </author>
    </item>
    <item>
      <title>Toll-like Receptor 4 Knockout Mice are Protected Against PMOS-like Pathogenesis</title>
      <link>https://escholarship.org/uc/item/0dj1k8vq</link>
      <description>Polyendocrine metabolic ovarian syndrome (PMOS), formerly termed polycystic ovary syndrome (PCOS), is a reproductive disorder with heterogeneous symptoms and severity. Despite extensive research documenting chronic immune dysfunction as a hallmark of PMOS, the specific mechanisms of immune activation remain poorly understood. Emerging evidence suggests that gut-derived bacterial endotoxins, particularly lipopolysaccharide (LPS), can breach intestinal barriers and trigger systemic inflammation via Toll-like receptor 4 (TLR4). This study examined the role of TLR4 in PMOS-like pathology using a letrozole (LET)-induced mouse model. In LET-treated wild-type female mice, serum LPS and its carrier protein LBP were elevated compared to LET-treated TLR4-/- mice. Additionally, TLR4 deficiency attenuated multiple PMOS-like features, including elevated luteinizing hormone, anovulation, and metabolic dysfunction. LET-treated TLR4-/- mice also preserved estrous cycling and fertility, maintained...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0dj1k8vq</guid>
      <pubDate>Thu, 30 Jul 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Wiggins, Kiara</name>
      </author>
      <author>
        <name>Del Mundo, Zena</name>
      </author>
      <author>
        <name>Angulo, Julio Ayala</name>
      </author>
      <author>
        <name>Naidu, Nandini</name>
      </author>
      <author>
        <name>Saba, Angelina</name>
      </author>
      <author>
        <name>Zhou, Lily</name>
      </author>
      <author>
        <name>Garcia, Christopher</name>
      </author>
      <author>
        <name>Nguyen, Christy M</name>
        <uri>https://orcid.org/0000-0002-3897-6207</uri>
      </author>
      <author>
        <name>Ujagar, Naveena</name>
      </author>
      <author>
        <name>De La Torre, Jamie-Jean</name>
        <uri>https://orcid.org/0000-0002-4829-7021</uri>
      </author>
      <author>
        <name>De Robles, Gabriela</name>
      </author>
      <author>
        <name>Rivera, Angie</name>
      </author>
      <author>
        <name>Trinh, Davina</name>
      </author>
      <author>
        <name>Tinoco, Roberto</name>
      </author>
      <author>
        <name>Kauffman, Alexander S</name>
      </author>
      <author>
        <name>Thackray, Varykina G</name>
      </author>
      <author>
        <name>Agrawal, Anshu</name>
        <uri>https://orcid.org/0000-0003-4898-9615</uri>
      </author>
      <author>
        <name>Seldin, Marcus</name>
      </author>
      <author>
        <name>Pacheco-Sanchez, Gabriela</name>
      </author>
      <author>
        <name>Nicholas, Dequina A</name>
      </author>
    </item>
    <item>
      <title>A Case of Recurrent Pulmonary Coccidioidomycosis Highlighting Gaps in Access to Care in California</title>
      <link>https://escholarship.org/uc/item/3cg4809g</link>
      <description>&lt;p&gt;Coccidioidomycosis is a fungal infection endemic to the southwestern US that affects both immunocompetent and immunocompromised individuals. Poorly controlled Diabetes Mellitus (DM), a well-known immunocompromised state, can lead to increased severity and progression of pulmonary coccidioidomycosis. Effective management of severe pulmonary coccidioidomycosis requires prolonged antifungal therapy, radiographic monitoring, and consistent outpatient follow-up.&lt;/p&gt;&lt;p&gt;We present the case of a 54-year-old male with type 2 DM who was hospitalized in 2023 for primary pulmonary coccidioidomycosis but subsequently lost insurance, which hindered management of both his DM and pulmonary care. In 2024, the patient presented to our free clinic with uncontrolled DM and a severe relapse of pulmonary coccidioidomycosis supported by both radiological and symptomatic evidence. His clinical course illustrates how gaps in health coverage prevented optimal management of uncontrolled DM, which, combined...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3cg4809g</guid>
      <pubDate>Fri, 24 Jul 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Shaikh, Hassan</name>
      </author>
      <author>
        <name>Garcia-Medina, Alexandra</name>
      </author>
      <author>
        <name>Shah, Usman</name>
      </author>
    </item>
    <item>
      <title>Long COVID sequelae in heart transplant recipients</title>
      <link>https://escholarship.org/uc/item/7nb1c0t0</link>
      <description>Post acute sequelae of SARS-CoV-2 infection (also known as Long COVID) have been defined as symptoms that persist after 3 months from initial acute episode of COVID-19. While the pathophysiology and mechanisms that cause Long COVID are hypothesized as secondary to persistent inflammation and immune dysregulation, the burden of this disease remains difficult to estimate due to varied symptomatology. Solid-organ transplant recipients in particular remain a vulnerable population that has been disproportionately affected by the COVID-19 pandemic, and the impact of Long COVID among orthotopic heart transplant recipients (OHTRs)-a patient population on chronic immunosuppressive therapy-remains incompletely characterized. We sought to evaluate patient-reported Long COVID symptoms between OHTRs compared to patients with baseline cardiomyopathy. We conducted a prospective survey-based study of adult OHTRs and cardiomyopathy control patients with documented SARS-CoV-2 infection. Participants...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7nb1c0t0</guid>
      <pubDate>Thu, 2 Jul 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Lees, Christopher R</name>
      </author>
      <author>
        <name>Morad, Tyler</name>
      </author>
      <author>
        <name>Webb, Martine</name>
      </author>
      <author>
        <name>Sim, Myung S</name>
      </author>
      <author>
        <name>Hsu, Jeffrey J</name>
        <uri>https://orcid.org/0000-0002-9971-5916</uri>
      </author>
    </item>
    <item>
      <title>Disparities in Depression Among Older Asian, Native Hawaiian, and Pacific Islander Patients With Lung Cancer.</title>
      <link>https://escholarship.org/uc/item/46q710wt</link>
      <description>&lt;h4&gt;Introduction&lt;/h4&gt;Approximately 12.4% of patients with lung cancer experience depression after cancer diagnosis. Asian, Native Hawaiian, and Pacific Islanders (ANHPIs) constitute a large group with heterogeneity. The aim of this study is to examine the racial differences in depression risk, comparing overall ANHPI and ANHPI ethnic groups to non-Hispanic White (NHW) patients with lung cancer.&lt;h4&gt;Method&lt;/h4&gt;We utilized the Surveillance, Epidemiology and End Results (SEER)-Medicare and SEER-Consumer Assessment of Healthcare Providers and System (CAHPS) dataset. We included patients with primary lung cancer who were aged 66 and older, diagnosed from 2000 to 2017 with full coverage of Medicare Part A and B. One ANHPI patient with lung cancer was matched to three NHW patients with lung cancer based on sex, diagnosis age, and diagnosis year. We used the Cox proportional hazards model to estimate the differences in depression incidence among ANHPI and NHW patients with lung cancer.&lt;h4&gt;Results&lt;/h4&gt;Overall...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/46q710wt</guid>
      <pubDate>Thu, 2 Jul 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Pan, Yancen</name>
      </author>
      <author>
        <name>Chang, Chun-Pin</name>
      </author>
      <author>
        <name>Wong, Nathan</name>
      </author>
      <author>
        <name>Nianogo, Roch</name>
      </author>
      <author>
        <name>Rao, Jianyu</name>
      </author>
      <author>
        <name>Varghese, Thomas</name>
      </author>
      <author>
        <name>Zhang, Zuo-Feng</name>
      </author>
      <author>
        <name>Hashibe, Mia</name>
      </author>
    </item>
    <item>
      <title>Navigating the Complex Interplay of Metabolic Health and Perioperative Risk</title>
      <link>https://escholarship.org/uc/item/0vx174tp</link>
      <description>Corresponding Author</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0vx174tp</guid>
      <pubDate>Fri, 19 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Zuniga, Eric</name>
      </author>
      <author>
        <name>Farestveit, Leanne</name>
      </author>
      <author>
        <name>Lee, Andy Y</name>
      </author>
    </item>
    <item>
      <title>The Evolving Landscape of Systemic Therapy for Liposarcoma.</title>
      <link>https://escholarship.org/uc/item/9z817091</link>
      <description>&lt;h4&gt;Background/objectives&lt;/h4&gt;Liposarcoma represents a heterogeneous group of mesenchymal malignancies with distinct molecular profiles and clinical behaviors. While localized disease is managed with surgical resection, advanced or metastatic liposarcoma poses a significant therapeutic challenge due to limited response to traditional cytotoxic chemotherapy. This review summarizes current evidence-based systemic therapies and highlights recent advances in subtype-driven treatment strategies.&lt;h4&gt;Methods&lt;/h4&gt;We review key clinical trials supporting the use of anthracycline regimens, trabectedin, eribulin, and nuclear export inhibition with selinexor, as well as emerging targeted approaches directed at MDM2 and CDK4 amplification. In addition, we discuss the evolving role of immunotherapy, including checkpoint inhibitors and engineered T-cell receptor therapies targeting cancer-testis antigens.&lt;h4&gt;Results&lt;/h4&gt;Integrating molecular biology with therapeutic development, we emphasize...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9z817091</guid>
      <pubDate>Thu, 18 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Kim, Hee</name>
      </author>
      <author>
        <name>Sarkari, Akshat</name>
      </author>
      <author>
        <name>Chow, Warren</name>
      </author>
    </item>
    <item>
      <title>New Investigations of Stellate Ganglion Block With ABP-450 (PrabotulinumtoxinA) in Rats</title>
      <link>https://escholarship.org/uc/item/3857214v</link>
      <description>New Investigations of Stellate Ganglion Block With ABP-450 (PrabotulinumtoxinA) in Rats</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3857214v</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guo, Zhi-Ling</name>
        <uri>https://orcid.org/0000-0001-7817-6872</uri>
      </author>
      <author>
        <name>Tran, Robert MN</name>
      </author>
      <author>
        <name>Abdul-Musawir, Najeebah</name>
      </author>
      <author>
        <name>Baird, Theodore J</name>
      </author>
      <author>
        <name>Oh, Chad K</name>
      </author>
    </item>
    <item>
      <title>Characterization and clinical management of adverse events following treatment with repotrectinib: a TRIDENT-1 analysis.</title>
      <link>https://escholarship.org/uc/item/39201535</link>
      <description>&lt;h4&gt;Background&lt;/h4&gt;Repotrectinib, a next-generation ROS1/TRK tyrosine kinase inhibitor, is approved for ROS1 fusion-positive non-small cell lung cancer and NTRK fusion-positive solid tumors. Its side effects and safety management strategies require further characterization.&lt;h4&gt;Patients and methods&lt;/h4&gt;The safety profile of repotrectinib (treatment-emergent/related adverse events [TEAEs/TRAEs]) was established in patients who initiated treatment at the recommended dose (160 mg daily [QD] for 14 days, then 160 mg twice daily [BID]) across all cohorts of the global, multicenter phase 1/2 TRIDENT-1 study. AE management strategies were outlined.&lt;h4&gt;Results&lt;/h4&gt;In 472 patients, the most common TRAEs (dizziness [58%] and dysgeusia [50%]) were likely TRK inhibition-related. Median relative dose intensity was 90%; 14% (n = 66/472) of patients did not increase their initial QD dose to BID (mostly due to CNS AEs). Rates of dizziness (median onset, 7 days) were similar in patients with/without...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/39201535</guid>
      <pubDate>Mon, 15 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Drilon, Alexander</name>
      </author>
      <author>
        <name>Cho, Byoung</name>
      </author>
      <author>
        <name>Camidge, D</name>
      </author>
      <author>
        <name>Nagasaka, Misako</name>
      </author>
      <author>
        <name>Besse, Benjamin</name>
      </author>
      <author>
        <name>Solomon, Benjamin</name>
      </author>
      <author>
        <name>Goto, Koichi</name>
      </author>
      <author>
        <name>Wolf, Jürgen</name>
      </author>
      <author>
        <name>Popat, Sanjay</name>
      </author>
      <author>
        <name>Felip, Enriqueta</name>
      </author>
      <author>
        <name>Yang, Nong</name>
      </author>
      <author>
        <name>de Langen, Adrianus</name>
      </author>
      <author>
        <name>Lu, Shun</name>
      </author>
      <author>
        <name>Velcheti, Vamsidhar</name>
      </author>
      <author>
        <name>Lin, Andrew</name>
      </author>
      <author>
        <name>Calvet, Christophe</name>
      </author>
      <author>
        <name>Li, Li</name>
      </author>
      <author>
        <name>Tschaika, Marina</name>
      </author>
      <author>
        <name>Afsar, Salman</name>
      </author>
      <author>
        <name>Yang, Haisu</name>
      </author>
      <author>
        <name>Lin, Jessica</name>
      </author>
    </item>
    <item>
      <title>Clinical Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Among Older Patients Hospitalized for Heart Failure With Reduced Ejection Fraction.</title>
      <link>https://escholarship.org/uc/item/9q90z5xt</link>
      <description>BACKGROUND: SGLT2 (sodium-glucose cotransporter-2) inhibitors (SGLT2i) reduce cardiovascular events in randomized controlled trials of patients with heart failure with reduced ejection fraction (HFrEF), but these trials enrolled outpatient, relatively younger patients (median age 66-67). The effectiveness of SGLT2i in older patients hospitalized for HFrEF in routine US clinical practice is not well studied.
METHODS: This study included Medicare beneficiaries aged ≥65 years hospitalized for HFrEF and eligible for SGLT2i in Get with the Guidelines-Heart Failure between July 1, 2021 and June 30, 2023. Primary outcomes were 30-day and 1-year all-cause mortality, all-cause readmission, and HF readmission. Association between SGLT2i and outcomes was assessed with Cox regression and overlap weighting using propensity score estimates.
RESULTS: A total of 8847 patients were eligible for but not prescribed SGLT2i at hospital admission (Median age 77; 40% women; median left ventricular EF...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9q90z5xt</guid>
      <pubDate>Wed, 3 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Brownell, Nicholas</name>
        <uri>https://orcid.org/0000-0001-8156-0808</uri>
      </author>
      <author>
        <name>Solomon, Nicole</name>
      </author>
      <author>
        <name>Greene, Stephen J</name>
      </author>
      <author>
        <name>Chiswell, Karen</name>
      </author>
      <author>
        <name>Vaduganathan, Muthiah</name>
      </author>
      <author>
        <name>Yancy, Clyde</name>
      </author>
      <author>
        <name>Hsue, Priscilla</name>
      </author>
      <author>
        <name>Ziaeian, Boback</name>
        <uri>https://orcid.org/0000-0001-9787-3649</uri>
      </author>
      <author>
        <name>Fonarow, Gregg C</name>
        <uri>https://orcid.org/0000-0002-3192-8093</uri>
      </author>
    </item>
    <item>
      <title>Addition of pulsed electric field ablation to SBRT for lung tumors: effect on health-related quality of life</title>
      <link>https://escholarship.org/uc/item/8vx0p27z</link>
      <description>INTRODUCTION: Treatment indications for oligometastatic/oligoprogressive lung tumors are growing. Safety and lack of detrimental effect on patients' quality of life are critical for novel local therapies.
METHODS: We tested that the additive effect of pulsed electric field (PEF) ablation with lower-dose stereotactic body radiation therapy (SBRT) on health-related quality of life (HRQoL) as a secondary endpoint in a prospective clinical trial. FACT-Lung Cancer Subscale (FACT-LCS) and FACT-General domain surveys were collected at screening, 3 months, and 12 months. Functional clinical data included forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and diffusing capacity of the lung for carbon monoxide (DLCO).
RESULTS: Six patients with eight tumors were enrolled. Baseline well-being domain scores were: Physical 25.9 (Std Dev 2.3), Social 21.0 (Std Dev 6.9), Emotional 17.3 (Std Dev 4.7), Functional 21.2 (Std Dev 5.8), and LCS 19.4 (Std Dev 5.3). There were...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8vx0p27z</guid>
      <pubDate>Wed, 3 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Harris, Jeremy P</name>
        <uri>https://orcid.org/0000-0003-1231-4798</uri>
      </author>
      <author>
        <name>Boyd, Christina</name>
      </author>
      <author>
        <name>Shi, Mengying</name>
      </author>
      <author>
        <name>Reilly, Michael</name>
        <uri>https://orcid.org/0000-0003-2481-6728</uri>
      </author>
      <author>
        <name>Simon, Aaron</name>
        <uri>https://orcid.org/0000-0003-4685-2711</uri>
      </author>
      <author>
        <name>Seyedin, Steven N</name>
      </author>
      <author>
        <name>Chen, Wen-Pin</name>
      </author>
      <author>
        <name>Nagasaka, Misako</name>
      </author>
      <author>
        <name>Abi-Jaoudeh, Nadine</name>
        <uri>https://orcid.org/0000-0001-6163-8524</uri>
      </author>
      <author>
        <name>Hoyt, Michael A</name>
        <uri>https://orcid.org/0000-0003-2274-1902</uri>
      </author>
    </item>
    <item>
      <title>Multi-Country Human-to-Human Andes Virus Outbreak on a Cruise Ship: A Disaster Report on Prehospital, Healthcare Facility, and Public Health System Challenges – Essential Knowledge for Frontline Clinicians</title>
      <link>https://escholarship.org/uc/item/75r8j97p</link>
      <description>&lt;p&gt;The Andes Virus (ANDV) outbreak reported on 2 May 2026 aboard a luxury vessel departing from Ushuaia, Patagonia, Argentina, was caused by an &lt;em&gt;Orthohantavirus&lt;/em&gt; that is unique in its person-to-person transmissibility in contrast to zoonotic transmission characteristic of better-known hantaviruses. Outbreak containment requires coordinated international management because passengers and crew embarked and disembarked at several international ports of call prior to outbreak recognition, resulting in cross-border transmission potential. Among those who disembarked, several traveled on flights to various international destinations. Cases have subsequently been identified in multiple countries, including the Tristan da Cunha (United Kingdon territory), Spain, France, Switzerland, South Africa, and Canada. International health authorities implemented containment measures once notified, including contact tracing, quarantine, and isolation.&lt;/p&gt;&lt;p&gt;ANDV poses unique risks due to...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/75r8j97p</guid>
      <pubDate>Fri, 22 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Marty, Aileen M.</name>
      </author>
      <author>
        <name>Beÿ, Christian K.</name>
      </author>
      <author>
        <name>Koenig, Kristi L.</name>
      </author>
    </item>
    <item>
      <title>PFKM governs metabolic shifts throughout skeletal muscle differentiation</title>
      <link>https://escholarship.org/uc/item/84b6w504</link>
      <description>Metabolism is known to influence cell identity, but the underlying mechanisms remain unclear. Here we reveal spatiotemporal dynamics of phosphofructokinase 1 (PFK1), a key glycolytic enzyme, within the skeletal muscle lineage. The expression of PFKM (the muscle isoform of PFK1) is low in muscle stem cells and increases during differentiation. Mechanistically, Wnt signalling rapidly induces lysosomal degradation of PFKM through a methyl arginine degron motif, which gets selectively methylated by the protein arginine methyltransferase (PRMT1) and delivered to lysosomes through microautophagy. PFKM degradation shifts glucose metabolism from glycolysis to the pentose phosphate pathway. PFKM overexpression increases glycolysis and promotes differentiation into terminally differentiated myofibres. On the other hand, PFKM knockdown blunts differentiation, which can be rescued by supplementation with the downstream glycolytic intermediate 3-phosphoglycerate. In sum, our findings highlight...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/84b6w504</guid>
      <pubDate>Mon, 18 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Campos, Melissa</name>
      </author>
      <author>
        <name>Nguyen, Steven T</name>
      </author>
      <author>
        <name>Kong, Xiangduo</name>
      </author>
      <author>
        <name>Yang, Ying</name>
      </author>
      <author>
        <name>Watson, Richard L</name>
        <uri>https://orcid.org/0000-0002-8931-9370</uri>
      </author>
      <author>
        <name>Gromova, Anastasia</name>
      </author>
      <author>
        <name>Livelo, Catherine R</name>
      </author>
      <author>
        <name>Franco, Carolina N</name>
      </author>
      <author>
        <name>Cabral, Julia E</name>
      </author>
      <author>
        <name>Seabrook, Laurence J</name>
      </author>
      <author>
        <name>Dai, Shengqi</name>
      </author>
      <author>
        <name>Liu, Yingzi</name>
      </author>
      <author>
        <name>Zhou, Mingqi</name>
        <uri>https://orcid.org/0009-0007-7643-7873</uri>
      </author>
      <author>
        <name>Hanse, Eric A</name>
      </author>
      <author>
        <name>Sumigray, Kaelyn</name>
      </author>
      <author>
        <name>La Spada, Albert R</name>
      </author>
      <author>
        <name>Seldin, Marcus M</name>
        <uri>https://orcid.org/0000-0001-8026-4759</uri>
      </author>
      <author>
        <name>Plikus, Maksim V</name>
      </author>
      <author>
        <name>Nicholas, Dequina A</name>
      </author>
      <author>
        <name>McNulty, Reginald</name>
      </author>
      <author>
        <name>Kong, Mei</name>
        <uri>https://orcid.org/0000-0001-8139-2349</uri>
      </author>
      <author>
        <name>Yokomori, Kyoko</name>
      </author>
      <author>
        <name>Albrecht, Lauren V</name>
      </author>
    </item>
    <item>
      <title>Language barriers and pain disparities in pediatric emergency settings: A call for action</title>
      <link>https://escholarship.org/uc/item/8hc7s48c</link>
      <description>Language barriers and pain disparities in pediatric emergency settings: A call for action</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8hc7s48c</guid>
      <pubDate>Fri, 15 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Lim, Paulina S</name>
      </author>
      <author>
        <name>Fortier, Michelle A</name>
      </author>
      <author>
        <name>Bender, Miriam</name>
        <uri>https://orcid.org/0000-0003-2457-1652</uri>
      </author>
      <author>
        <name>Campos, Belinda</name>
      </author>
      <author>
        <name>Heyming, Theodore</name>
      </author>
      <author>
        <name>Kain, Zeev N</name>
      </author>
    </item>
    <item>
      <title>Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial</title>
      <link>https://escholarship.org/uc/item/47b4m2bp</link>
      <description>BACKGROUND: We conducted a randomized, double-blinded pilot trial to compare the impact of two electroacupuncture (EA) regimens on co-occurring neuropsychiatric symptoms among breast cancer survivors (BCS).
METHODS: BCS who self-reported cognitive impairment, fatigue, insomnia, or psychological distress were randomized (1:1) to receive ten weekly EA to target either neuropsychiatric-specific (nEA) or non-neuropsychiatric-specific (sEA) acupoints. Primary endpoints were the within-group pre-post effect sizes (Glass's Δ) in symptom severities, adjusted for multiple comparisons (p-adjusted). Outcomes were assessed using neurocognitive tests (CANTAB®), PROs (FACT-Cog, MFSI-SF, EORTC QLQ-C30), plasma biomarkers, and neuroimaging. Responders were defined by reliable change index (for objective cognition) or MCID (for PROs).
RESULTS: Thirty-five were recruited, with 30 (86%) completing all sessions. The mean (±SD) age was 58.2 (±12.2) years, and 86% reported co-occurring symptoms. Following...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/47b4m2bp</guid>
      <pubDate>Fri, 24 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Ng, Ding Quan</name>
      </author>
      <author>
        <name>Heshmatipour, Matthew</name>
      </author>
      <author>
        <name>Trudeau, Julia</name>
        <uri>https://orcid.org/0000-0002-3250-1876</uri>
      </author>
      <author>
        <name>Sridhar, Apeksha</name>
      </author>
      <author>
        <name>Pluimer, Brock</name>
      </author>
      <author>
        <name>Drayson, Olivia GG</name>
      </author>
      <author>
        <name>Lavasani, Sayeh M</name>
      </author>
      <author>
        <name>Parajuli, Ritesh</name>
        <uri>https://orcid.org/0000-0002-1801-5783</uri>
      </author>
      <author>
        <name>Lee, Sanghoon</name>
      </author>
      <author>
        <name>Agrawal, Anshu</name>
        <uri>https://orcid.org/0000-0003-4898-9615</uri>
      </author>
      <author>
        <name>Acharya, Munjal M</name>
        <uri>https://orcid.org/0000-0002-7767-5642</uri>
      </author>
      <author>
        <name>Limoli, Charles L</name>
      </author>
      <author>
        <name>Harris, Richard E</name>
      </author>
      <author>
        <name>Xie, Lifang</name>
      </author>
      <author>
        <name>Malik, Shaista</name>
      </author>
      <author>
        <name>Chan, Alexandre</name>
        <uri>https://orcid.org/0000-0003-4391-4219</uri>
      </author>
    </item>
    <item>
      <title>Chronic Thromboembolism Phenotypes after Acute Pulmonary Embolism: Identification with the SEARCH Algorithm.</title>
      <link>https://escholarship.org/uc/item/9p4254p5</link>
      <description>RATIONALE: Chronic dyspnea and exercise impairment are common after acute pulmonary embolism but poorly characterised.
OBJECTIVES: We performed a prospective observational study to validate an algorithm to diagnose discrete post-pulmonary embolism outcomes, including chronic thromboembolism phenotypes.
METHODS: Six pulmonologists independently reviewed records from 150 consecutive patients three or more months after acute pulmonary embolism who had undergone a stepwise diagnostic algorithm (SEARCH): symptom screen, cardiopulmonary exercise testing, pulmonary arterial perfusion scans, resting echocardiography, confirmatory imaging, and hemodynamic measurements by rest and exercise right heart catheterisation. Clinical data were reviewed after the first post-pulmonary embolism evaluation and then six months later.
MEASUREMENTS AND MAIN RESULTS: Symptomatic recovery was most common and occurred in 66.2% of patients during the final evaluation. Dyspnea without discernable physiological...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9p4254p5</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Morris, Timothy A</name>
        <uri>https://orcid.org/0000-0002-5122-9193</uri>
      </author>
      <author>
        <name>Dakaeva, Khadizhat</name>
      </author>
      <author>
        <name>Alotaibi, Mona</name>
      </author>
      <author>
        <name>McGuire, W Cameron</name>
      </author>
      <author>
        <name>Stringer, William</name>
      </author>
      <author>
        <name>Chung, Jina</name>
      </author>
      <author>
        <name>Fargo, Ramiz</name>
      </author>
      <author>
        <name>Yagmour, Bassam</name>
      </author>
      <author>
        <name>Chinchilla, Dinora</name>
      </author>
      <author>
        <name>Vintch, Janine RE</name>
      </author>
      <author>
        <name>Aries, Savannah</name>
      </author>
      <author>
        <name>Ma, Janet</name>
      </author>
      <author>
        <name>Jurica, James</name>
      </author>
      <author>
        <name>Fernandes, Timothy M</name>
        <uri>https://orcid.org/0000-0001-9319-4200</uri>
      </author>
    </item>
    <item>
      <title>Cost-Effectiveness of Medical Therapy for Heart&amp;nbsp;Failure With Mildly Reduced and Preserved Ejection Fraction</title>
      <link>https://escholarship.org/uc/item/9m65555p</link>
      <description>BACKGROUND: Three medications are now guideline-recommended treatments for heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), however, the cost-effectiveness of these agents in combination has yet to be established.
OBJECTIVES: The purpose of this study was to determine the cost-effectiveness of mineralocorticoid receptor antagonists (MRA), angiotensin receptor-neprilysin inhibitors (ARNIs), and sodium glucose co-transporter 2 inhibitors (SGLT2is) in individuals with HFmrEF/HFpEF.
METHODS: Using a 3-state Markov model, we performed a cost-effectiveness study using simulated cohorts of 1,000 patients with HFmrEF and HFpEF. Treatment with 1-, 2-, and 3-drug combinations was modeled. Based on a United States health care sector perspective, outcome data was used to calculate incremental cost-effectiveness ratios (ICERs) in 2023 United States dollars based on a 30-year time horizon.
RESULTS: Treatment with MRA, MRA+SGLT2i, and MRA+SGLT2i+ARNI therapy resulted...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9m65555p</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Dixit, Neal M</name>
      </author>
      <author>
        <name>Truong, Katie P</name>
      </author>
      <author>
        <name>Vaduganathan, Muthiah</name>
      </author>
      <author>
        <name>Ziaeian, Boback</name>
        <uri>https://orcid.org/0000-0001-9787-3649</uri>
      </author>
      <author>
        <name>Fonarow, Gregg C</name>
        <uri>https://orcid.org/0000-0002-3192-8093</uri>
      </author>
    </item>
    <item>
      <title>Circulating Asprosin Concentrations and Body Weight Changes in Postmenopausal Women: Findings from the Women’s Health Initiative</title>
      <link>https://escholarship.org/uc/item/5kz7v1sx</link>
      <description>BACKGROUND: Weight changes after menopause contribute to cardiometabolic risk, yet hormonal determinants of long-term weight trajectories remain incompletely understood. Asprosin, a fasting-induced adipokine involved in hepatic gluconeogenesis and appetite regulation, has been associated with metabolic disease, although its prospective role in affecting weight change remains unknown.
OBJECTIVES: This study aimed to examine whether plasma asprosin concentrations are directly and prospectively associated with changes in body weight and body composition among postmenopausal women.
METHODS: In a case-control study of 4020 postmenopausal women (1987 newly developed/incident diabetes cases and 2033 matched controls) nested within the Women's Health Initiative, we prospectively evaluated participants' baseline plasma concentrations of asprosin in relation to 3-y changes in weight, measures of central obesity, and the risk of major weight gain or loss (≥7% of baseline weight). Associations...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5kz7v1sx</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Ng, Stella</name>
      </author>
      <author>
        <name>Yang, Bo</name>
      </author>
      <author>
        <name>Li, Jie</name>
      </author>
      <author>
        <name>Silva, Elizabeth S</name>
      </author>
      <author>
        <name>Manson, JoAnn E</name>
      </author>
      <author>
        <name>Phillips, Lawrence S</name>
      </author>
      <author>
        <name>Reiner, Alexander P</name>
      </author>
      <author>
        <name>Chopra, Atul R</name>
      </author>
      <author>
        <name>Liu, Simin</name>
        <uri>https://orcid.org/0000-0003-2098-3844</uri>
      </author>
    </item>
    <item>
      <title>Are high residual chlorhexidine skin concentrations associated with improved clinical outcomes? Lessons from the CLEAR trial</title>
      <link>https://escholarship.org/uc/item/8qn404qs</link>
      <description>Residual chlorhexidine gluconate (CHG) skin concentrations are thought to improve disease prevention. In the Changing Lives by Eradicating Antibiotic Resistance (CLEAR) trial, posthospitalization decolonization of MRSA carriers reduced MRSA infection and all-cause infection, but higher residual CHG concentrations did not improve outcomes. CHG concentration may indicate bathing quality, but high residual concentrations may not be necessary for benefit.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8qn404qs</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Khoja, Roya</name>
      </author>
      <author>
        <name>Catuna, Tabitha D</name>
      </author>
      <author>
        <name>Gussin, Gabrielle M</name>
      </author>
      <author>
        <name>Nguyen, Kevin</name>
      </author>
      <author>
        <name>Singh, Raveena D</name>
      </author>
      <author>
        <name>Hayden, Mary K</name>
      </author>
      <author>
        <name>Miller, Loren G</name>
        <uri>https://orcid.org/0000-0003-0487-1711</uri>
      </author>
      <author>
        <name>Huang, Susan S</name>
        <uri>https://orcid.org/0000-0001-6748-3447</uri>
      </author>
    </item>
    <item>
      <title>Sexual dimorphism shapes renal metabolic adaptation to a ketogenic diet</title>
      <link>https://escholarship.org/uc/item/26w0671j</link>
      <description>While kidneys are essential for maintaining systemic metabolic homeostasis and exhibit sexual dimorphism, the effects of sex and environmental factors, such as diet, on renal metabolism remain unclear. Using kidney-specific arteriovenous (AV) metabolomics, in vivo isotope tracing, and transcriptomics, we discover profound sex differences in kidney metabolic reprogramming under ketogenic diet (KD) in C57BL/6J mice. Tissue metabolomics shows the accumulation of aldosterone and acylcarnitines exclusively in female kidneys under a normal chow (NC) diet, suggesting basal sex differences in sodium and fatty acid metabolism. Under KD, AV metabolomics reveals that only female kidneys activate ketogenesis and gluconeogenesis, supported by transcriptional sex differences in related rate-limiting enzymes and transporters. Given the widespread public and clinical interest in KD for treating epilepsy, metabolic disorders, and cancers, our findings underscore the importance of considering sex...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/26w0671j</guid>
      <pubDate>Wed, 8 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Kelly, Miranda E</name>
      </author>
      <author>
        <name>Hoffner, Lauren A</name>
      </author>
      <author>
        <name>Ramirez, Cuauhtemoc B</name>
      </author>
      <author>
        <name>Anica, Alexis L</name>
      </author>
      <author>
        <name>Kim, Joohwan</name>
      </author>
      <author>
        <name>Tong, Gregory</name>
      </author>
      <author>
        <name>Kim, Yeojin</name>
      </author>
      <author>
        <name>Mannepalli, Vyshnavi</name>
      </author>
      <author>
        <name>Choi, Wonsuk</name>
      </author>
      <author>
        <name>Jang, Ki-Hong</name>
      </author>
      <author>
        <name>Alam, Yasmine H</name>
      </author>
      <author>
        <name>Jung, Sunhee</name>
      </author>
      <author>
        <name>Le, Johnny</name>
      </author>
      <author>
        <name>Lopez, Miranda L</name>
      </author>
      <author>
        <name>Rubtsova, Varvara I</name>
      </author>
      <author>
        <name>Bae, Hosung</name>
      </author>
      <author>
        <name>Chun, Yujin</name>
      </author>
      <author>
        <name>Song, Won-Suk</name>
      </author>
      <author>
        <name>Tamburini, Ian J</name>
      </author>
      <author>
        <name>Schuster, Victor L</name>
      </author>
      <author>
        <name>Anton-Culver, Hoda</name>
        <uri>https://orcid.org/0000-0002-9603-0110</uri>
      </author>
      <author>
        <name>Lau, Wei Ling</name>
        <uri>https://orcid.org/0000-0002-3118-1073</uri>
      </author>
      <author>
        <name>Martinez, Thomas F</name>
        <uri>https://orcid.org/0000-0002-4011-8164</uri>
      </author>
      <author>
        <name>Lee, Gina</name>
      </author>
      <author>
        <name>Jang, Cholsoon</name>
        <uri>https://orcid.org/0000-0002-4011-8164</uri>
      </author>
    </item>
    <item>
      <title>Evaluating the potential of acupuncture for Alzheimer’s disease treatment: A meta-analysis and systematic review of mouse model studies</title>
      <link>https://escholarship.org/uc/item/0sd9c8sj</link>
      <description>Acupuncture is an ancient practice that was developed within the framework of traditional Chinese medicine. While acupuncture has been recently proposed as a therapy for Alzheimer’s disease (AD), acupuncture effects are not well understood in terms of neural mechanisms. Here, we review and examine the studies that used AD mouse models and analyze the experiments where researchers administered electroacupuncture (EA) to AD mice to assess the potential therapeutic impact of acupuncture on disease pathology and cognitive function in controlled laboratory settings. We analyzed 29 relevant PubMed articles published between January 2014 and July 2025. Our results reveal that EA significantly reduces both amyloid-beta (Aβ) and phosphorylated tau (p-tau) levels and neuroinflammatory biomarkers, including molecular signatures for activated microglia and astrocytes in the brain. EA also enhances cognitive functions. While no study directly compared acupoint strategies, the indirect comparisons...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0sd9c8sj</guid>
      <pubDate>Wed, 8 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Yang, Mohan</name>
      </author>
      <author>
        <name>Tong, Liqi</name>
      </author>
      <author>
        <name>Guo, Zhiling</name>
      </author>
      <author>
        <name>Tan, Zhiqun</name>
      </author>
      <author>
        <name>Holmes, Todd C</name>
      </author>
      <author>
        <name>Yu, Zhaoxia</name>
        <uri>https://orcid.org/0000-0001-9700-1795</uri>
      </author>
      <author>
        <name>Xu, Xiangmin</name>
        <uri>https://orcid.org/0000-0002-5828-1533</uri>
      </author>
    </item>
    <item>
      <title>Editorial: Lipids in immunometabolism</title>
      <link>https://escholarship.org/uc/item/9cz6k3qh</link>
      <description>Editorial: Lipids in immunometabolism</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9cz6k3qh</guid>
      <pubDate>Thu, 26 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Nicoli, Francesco</name>
      </author>
      <author>
        <name>Agrawal, Anshu</name>
        <uri>https://orcid.org/0000-0003-4898-9615</uri>
      </author>
      <author>
        <name>Bonacina, Fabrizia</name>
      </author>
      <author>
        <name>Purvis, Gareth SD</name>
      </author>
    </item>
    <item>
      <title>Editorial: Transforming vaccine strategies: co-delivery systems for robust immunity and disease control</title>
      <link>https://escholarship.org/uc/item/4wb9r9n6</link>
      <description>Editorial: Transforming vaccine strategies: co-delivery systems for robust immunity and disease control</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4wb9r9n6</guid>
      <pubDate>Thu, 26 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Owais, Mohammad</name>
      </author>
      <author>
        <name>Tayyab, Saad</name>
      </author>
      <author>
        <name>Agrawal, Anshu</name>
        <uri>https://orcid.org/0000-0003-4898-9615</uri>
      </author>
      <author>
        <name>Furkan, Mohammad</name>
      </author>
    </item>
    <item>
      <title>When AI Writes Back: Ethical Considerations by Physicians on AI-Drafted Patient Message Replies.</title>
      <link>https://escholarship.org/uc/item/9fb33523</link>
      <description>The increasing burden of responding to large volumes of patient messages has become a key factor contributing to physician burnout. Generative AI (GenAI) shows great promise to alleviate this burden by automatically drafting patient message replies. The ethical implications of this use have however not been fully explored. To address this knowledge gap, we conducted a qualitative interview study with 21 physicians who participated in a GenAI pilot program. We found that notable ethical considerations expressed by the physician participants included oversight as ethical safeguard, transparency and patient consent of AI use, patient misunderstanding of AI's role, and patient privacy and data security as prerequisites. Additionally, our findings suggest that the physicians believe the ethical responsibility of using GenAI in this context primarily lies with users, not with the technology. These findings may provide useful insights into guiding the future implementation of GenAI in...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9fb33523</guid>
      <pubDate>Wed, 11 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Hu, Di</name>
      </author>
      <author>
        <name>Guo, Yawen</name>
      </author>
      <author>
        <name>Cho, Ha Na</name>
      </author>
      <author>
        <name>Chow, Emilie</name>
      </author>
      <author>
        <name>Mukamel, Dana B</name>
        <uri>https://orcid.org/0000-0003-4147-5785</uri>
      </author>
      <author>
        <name>Sorkin, Dara</name>
        <uri>https://orcid.org/0000-0003-0742-9240</uri>
      </author>
      <author>
        <name>Reikes, Andrew</name>
      </author>
      <author>
        <name>Perret, Danielle</name>
      </author>
      <author>
        <name>Pandita, Deepti</name>
        <uri>https://orcid.org/0009-0007-2791-2738</uri>
      </author>
      <author>
        <name>Zheng, Kai</name>
        <uri>https://orcid.org/0000-0003-4121-4948</uri>
      </author>
    </item>
    <item>
      <title>Chronic IL-21 exposure reshapes pulmonary environment, elevating risk of respiratory diseases</title>
      <link>https://escholarship.org/uc/item/0f77j559</link>
      <description>Age-related pulmonary diseases pose a significant health burden, yet the underlying mechanisms remain poorly understood. This study investigates the role of interleukin-21 (IL-21) in driving age-associated changes in lung function and immune responses. Using both murine models and human samples, we demonstrate that IL-21 induces a pro-inflammatory state in the lungs, characterized by increased levels of key inflammatory cytokines including TNF-α, IL-6, IL-33, CXCL-10, and IL-18. IL-21 exposure also promoted cellular senescence, evidenced by upregulation of senescence-associated genes and increased frequencies of KLRG1-positive T cells. Notably, IL-21 treatment led to significant alterations in lung macrophage phenotype and function. We observed increased lipid accumulation in macrophages, accompanied by upregulation of lipid uptake receptors TREM-2 and CD36. These changes were associated with elevated TGF-β secretion, suggesting a potential mechanism for IL-21-induced pulmonary...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0f77j559</guid>
      <pubDate>Thu, 26 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Agrawal, Sudhanshu</name>
      </author>
      <author>
        <name>Oyamada, Hugo</name>
      </author>
      <author>
        <name>Korvink, Nicholas Steven</name>
      </author>
      <author>
        <name>Zhou, Siyi</name>
      </author>
      <author>
        <name>de Melo Bento, Cleonice Alves</name>
      </author>
      <author>
        <name>Rahmatpanah, Farah</name>
      </author>
      <author>
        <name>Subramanian, Veedamali S</name>
      </author>
      <author>
        <name>Agrawal, Anshu</name>
        <uri>https://orcid.org/0000-0003-4898-9615</uri>
      </author>
    </item>
    <item>
      <title>HF STATS 2025: Heart Failure Epidemiology and Outcomes Statistics An Updated 2025 Report from the Heart Failure Society of America</title>
      <link>https://escholarship.org/uc/item/92m8c8s0</link>
      <description>HF STATS 2025: Heart Failure Epidemiology and Outcomes Statistics An Updated 2025 Report from the Heart Failure Society of America</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/92m8c8s0</guid>
      <pubDate>Wed, 25 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>MEMBERS, WRITING COMMITTEE</name>
      </author>
      <author>
        <name>Fonarow, Gregg C</name>
        <uri>https://orcid.org/0000-0002-3192-8093</uri>
      </author>
      <author>
        <name>Ahmad, Faraz S</name>
      </author>
      <author>
        <name>Ahmad, Tariq</name>
      </author>
      <author>
        <name>Albert, Nancy M</name>
      </author>
      <author>
        <name>Alexander, Kevin M</name>
      </author>
      <author>
        <name>Baker, William L</name>
      </author>
      <author>
        <name>Bozkurt, Biykem</name>
      </author>
      <author>
        <name>Breathett, Khadijah</name>
      </author>
      <author>
        <name>Carter, Spencer</name>
      </author>
      <author>
        <name>Cheng, Richard K</name>
      </author>
      <author>
        <name>Deswal, Anita</name>
      </author>
      <author>
        <name>Drazner, Mark H</name>
      </author>
      <author>
        <name>Dunlay, Shannon</name>
      </author>
      <author>
        <name>Gorodeski, Eiran Z</name>
      </author>
      <author>
        <name>Greene, Stephen J</name>
      </author>
      <author>
        <name>Heidenreich, Paul</name>
      </author>
      <author>
        <name>Hsich, Eileen</name>
      </author>
      <author>
        <name>Jones, Lenette</name>
      </author>
      <author>
        <name>Kanwar, Manreet</name>
      </author>
      <author>
        <name>Khazanie, Prateeti</name>
      </author>
      <author>
        <name>Khush, Kiran</name>
      </author>
      <author>
        <name>Koelling, Todd</name>
      </author>
      <author>
        <name>Lee, Christopher S</name>
      </author>
      <author>
        <name>Page, Robert</name>
      </author>
      <author>
        <name>Pandey, Ambarish</name>
      </author>
      <author>
        <name>Reza, Nosheen</name>
      </author>
      <author>
        <name>Sandhu, Alexander T</name>
      </author>
      <author>
        <name>Shah, Palak</name>
      </author>
      <author>
        <name>Stehlik, Josef</name>
      </author>
      <author>
        <name>Tedford, Ryan J</name>
      </author>
      <author>
        <name>Teerlink, John R</name>
      </author>
      <author>
        <name>Vest, Amanda R</name>
      </author>
      <author>
        <name>Yancy, Clyde</name>
      </author>
      <author>
        <name>Ziaeian, Boback</name>
        <uri>https://orcid.org/0000-0001-9787-3649</uri>
      </author>
    </item>
    <item>
      <title>National Trends and Disparities in Heart Failure Hospitalizations and Inpatient Outcomes Between 2010-2022</title>
      <link>https://escholarship.org/uc/item/1c86773d</link>
      <description>BACKGROUND: Limited data exist on trends and differential heart failure (HF) hospitalization rates, particularly when appropriate statistical age standardization is applied.
OBJECTIVES: This study aimed to assess temporal trends in age-standardized hospitalization rates and in-hospital mortality for primary HF hospitalizations among younger (&amp;lt;65 years) and older (&amp;gt;64 years) patients, stratified by sex, race/ethnicity, insurance status, and urban/rural hospital location.
METHODS: The National Inpatient Sample database was analyzed to identify adults who were hospitalized for HF between 2010 and 2022. HF hospitalization rates and in-hospital mortality trends were then examined across demographic strata.
RESULTS: In total, 14,287,733 weighted hospitalizations for HF were identified. Overall, age-standardized HF hospitalizations per 100,000 U.S. population showed a nonsignificant change from 406 in 2010 to 381 in 2014 (P = 0.14), followed by an increase to 447 in 2018 (P = 0.002)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1c86773d</guid>
      <pubDate>Wed, 25 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Agarwal, Manyoo A</name>
      </author>
      <author>
        <name>Ebrahimian, Shayan</name>
      </author>
      <author>
        <name>Yan, Amy</name>
      </author>
      <author>
        <name>Srivastava, Pratyakash K</name>
      </author>
      <author>
        <name>Jackson, Nicholas J</name>
      </author>
      <author>
        <name>Fonarow, Gregg C</name>
        <uri>https://orcid.org/0000-0002-3192-8093</uri>
      </author>
      <author>
        <name>Ziaeian, Boback</name>
        <uri>https://orcid.org/0000-0001-9787-3649</uri>
      </author>
    </item>
    <item>
      <title>Tenofovir-induced Fanconi syndrome: a case report and literature review.</title>
      <link>https://escholarship.org/uc/item/0041v4sm</link>
      <description>Abstract: 

                  Tenofovir disoproxil fumarate (TDF) is an antiviral medication with potential nephrotoxicity side effects. In this case report, a patient who had been taking TDF for five years was referred to nephrology clinic for hypophosphatemia. Additional labs demonstrated urinary phosphate wasting, glucosuria, hypokalemia, and hyperchloremic metabolic acidosis. Imaging revealed occult fractures. She was diagnosed with tenofovir-induced Fanconi syndrome with hypophosphatemic osteomalacia. TDF was switched to tenofovir alafenamide (TAF) and electrolyte deficiencies were treated with supplementation. However, phosphaturia and glucosuria persisted, prompting TAF switch to entecavir, which improved serum electrolytes and quality of life. Mild Fanconi syndrome was present at 6 months after TAF discontinuation, which highlights that tenofovir can have prolonged effects on proximal tubule dysfunction. Delays in the diagnosis of tenofovirinduced tubular toxicity can...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0041v4sm</guid>
      <pubDate>Wed, 25 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Park, Justin</name>
      </author>
      <author>
        <name>Lee, Frank</name>
        <uri>https://orcid.org/0000-0002-7217-1779</uri>
      </author>
      <author>
        <name>Yeam, Albert</name>
        <uri>https://orcid.org/0009-0004-0616-4302</uri>
      </author>
      <author>
        <name>Hamiduzzaman, Anum</name>
      </author>
      <author>
        <name>Anavim, Arash</name>
        <uri>https://orcid.org/0000-0002-9375-7015</uri>
      </author>
      <author>
        <name>Lau, Wei Ling</name>
        <uri>https://orcid.org/0000-0002-3118-1073</uri>
      </author>
    </item>
    <item>
      <title>Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations.</title>
      <link>https://escholarship.org/uc/item/4gp0r1vk</link>
      <description>&lt;h4&gt;Purpose&lt;/h4&gt;The mammalian target of rapamycin (mTOR) inhibitor everolimus is US Food and Drug Administration-approved for advanced pancreatic neuroendocrine neoplasms (pNENs), yet resistance is common, necessitating the identification of resistance mechanisms for effective treatment strategies. Previous studies suggest that targeting the aberrant expression of mTOR regulators p21-activated kinase 4 (PAK4) and nicotinamide phosphoribosyl transferase (NAMPT) sensitizes pNENs to everolimus. In this study, we queried a large real-world data set of pNENs, characterizing the molecular and immune landscapes, as well as the clinical outcomes associated with aberrant PAK4 and NAMPT expression.&lt;h4&gt;Methods&lt;/h4&gt;Two-hundred and ninety-four pNEN cases were analyzed using next-generation sequencing and whole-exome/whole-transcriptome sequencing. We stratified patients into clusters on the basis of median cutoff.&lt;h4&gt;Results&lt;/h4&gt;High expression of genes activated in response to mTOR activation...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4gp0r1vk</guid>
      <pubDate>Thu, 19 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Azar, Ibrahim</name>
      </author>
      <author>
        <name>Khan, Husain</name>
      </author>
      <author>
        <name>Bannoura, Sahar</name>
      </author>
      <author>
        <name>Gandhi, Nishant</name>
      </author>
      <author>
        <name>Uddin, Md</name>
      </author>
      <author>
        <name>Nagasaka, Misako</name>
      </author>
      <author>
        <name>Gong, Jun</name>
      </author>
      <author>
        <name>Nazha, Bassel</name>
      </author>
      <author>
        <name>Choucair, Khalil</name>
      </author>
      <author>
        <name>Vojjala, Nikhil</name>
      </author>
      <author>
        <name>Khushman, Mohd</name>
      </author>
      <author>
        <name>Soares, Heloisa</name>
      </author>
      <author>
        <name>El-Deiry, Wafik</name>
      </author>
      <author>
        <name>Philip, Philip</name>
      </author>
      <author>
        <name>El-Rayes, Bassel</name>
      </author>
      <author>
        <name>Chen, Herbert</name>
      </author>
      <author>
        <name>Lou, Emil</name>
      </author>
      <author>
        <name>Muqbil, Irfana</name>
      </author>
      <author>
        <name>Farrell, Alex</name>
      </author>
      <author>
        <name>Swensen, Jeffrey</name>
      </author>
      <author>
        <name>Oberley, Matthew</name>
      </author>
      <author>
        <name>Nabhan, Chadi</name>
      </author>
      <author>
        <name>Goel, Sanjay</name>
      </author>
      <author>
        <name>Shields, Anthony</name>
      </author>
      <author>
        <name>Mohammad, Ramzi</name>
      </author>
      <author>
        <name>Pasche, Boris</name>
      </author>
      <author>
        <name>Azmi, Asfar</name>
      </author>
    </item>
    <item>
      <title>Irradiation with a mixed heavy ion beam induces ovarian follicle loss and dose-dependent mixed ovarian tumor development</title>
      <link>https://escholarship.org/uc/item/5cg2s3qs</link>
      <description>Over 25% of active NASA astronauts are women who will be exposed to low daily doses and dose rates of galactic cosmic rays (GCR) in space. We hypothesized that exposing mice to a preliminary simulated GCR mixed heavy ion beam composed of iron, silicon, and titanium ions induces follicle depletion and dose-dependent ovarian tumors. Female mice were exposed to 10, or 20&amp;nbsp;cGy each of Fe, Si, and Ti ions or sham-irradiation in quick succession within 15&amp;nbsp;min for total doses of 0, 30, or 60&amp;nbsp;cGy of the three beams. 16&amp;nbsp;months later, their ovaries were removed. Hyperplasia of the ovarian surface epithelium (OSE) was noted in 13%, 59%, and 22% of the 0, 30, and 60&amp;nbsp;cGy irradiated mice, respectively. The prevalence of mixed ovarian tumors was 0, 6, and 89%, respectively, in the 0, 30, and 60&amp;nbsp;cGy groups. Low numbers of Ki67 positive OSE and tumor cells supported a benign tumor phenotype. In a separate study, Si ion irradiation alone at 32&amp;nbsp;cGy did not induce...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5cg2s3qs</guid>
      <pubDate>Thu, 12 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Parada, Kathleen N Leon</name>
      </author>
      <author>
        <name>Lawson, Gregory</name>
      </author>
      <author>
        <name>Chang, Polly</name>
      </author>
      <author>
        <name>Blakely, Eleanor A</name>
      </author>
      <author>
        <name>Bajwa, Lovleen</name>
      </author>
      <author>
        <name>Gramajo-Aponte, Kevin</name>
      </author>
      <author>
        <name>Getze, Samantha</name>
      </author>
      <author>
        <name>Luderer, Ulrike</name>
        <uri>https://orcid.org/0000-0002-8639-1326</uri>
      </author>
    </item>
    <item>
      <title>S4001 A Bowel Invader: Endometriosis Causing Partial Colon Obstruction</title>
      <link>https://escholarship.org/uc/item/80n450fv</link>
      <description>S4001 A Bowel Invader: Endometriosis Causing Partial Colon Obstruction</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/80n450fv</guid>
      <pubDate>Tue, 10 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Herekar, Anjali</name>
      </author>
      <author>
        <name>Banerjee, Shoujit</name>
      </author>
      <author>
        <name>McCracken, Trevor</name>
      </author>
      <author>
        <name>Masroor, Momin</name>
      </author>
      <author>
        <name>Balfour, Marie</name>
      </author>
      <author>
        <name>Tavangar, Amirali</name>
      </author>
      <author>
        <name>Samarasena, Jason</name>
        <uri>https://orcid.org/0000-0002-2981-3078</uri>
      </author>
      <author>
        <name>Nguyen, Peter</name>
      </author>
      <author>
        <name>Saad, Carlos</name>
      </author>
    </item>
    <item>
      <title>Naloxegol, an Oral Peripherally Acting Opioid Receptor Antagonist, Administered Concurrently with First-Line Systemic Therapy for Advanced Lung Adenocarcinoma (Alliance A221504): A Feasibility and Safety Study</title>
      <link>https://escholarship.org/uc/item/3hj1h4pk</link>
      <description>Background: Mu opioid receptors (MORs) in peripheral tissues mediate adverse effects of opioids that impair health-related quality of life (HRQoL) and may stimulate cancer progression via mitogenic signaling. Naloxegol, a peripherally acting MOR antagonist (PAMORA), is approved for opioid-induced constipation. Safety and efficacy of naloxegol have not been evaluated concurrently with systemic cancer therapy. Methods: We conducted a randomized, double-blind, placebo-controlled trial of naloxegol in patients with advanced lung adenocarcinoma starting first-line systemic therapy. Results: Only 50 patients were enrolled; the trial was terminated early due to slow accrual. Two of the three components of the feasibility primary endpoint were not met (accrual and PRO completion). At 6 months, FACT-L emotional well-being was better with naloxegol (p = 0.0113). There were trends towards better Trial Outcome Index (p = 0.0505) and physical well-being (p = 0.0628) with naloxegol. Bowel function...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3hj1h4pk</guid>
      <pubDate>Tue, 3 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Gupta, Pankaj</name>
      </author>
      <author>
        <name>Gupta, Kalpna</name>
      </author>
      <author>
        <name>Dockter, Travis</name>
      </author>
      <author>
        <name>Harlos, Elizabeth</name>
      </author>
      <author>
        <name>Chow, Selina</name>
      </author>
      <author>
        <name>Subbiah, Niveditha</name>
      </author>
      <author>
        <name>Ruddy, Kathryn J</name>
      </author>
      <author>
        <name>Bazhenova, Lyudmila</name>
        <uri>https://orcid.org/0000-0001-8764-4359</uri>
      </author>
      <author>
        <name>Terstriep, Shelby</name>
      </author>
      <author>
        <name>Huang, Chao H</name>
      </author>
      <author>
        <name>Kratzke, Robert A</name>
      </author>
      <author>
        <name>Vokes, Everett E</name>
      </author>
      <author>
        <name>Loprinzi, Charles L</name>
      </author>
    </item>
    <item>
      <title>Adequate Catchment Area Representation in Cancer Clinical Trials at NCI Designated Cancer Centers: The University of California Irvine Experience</title>
      <link>https://escholarship.org/uc/item/2r80c7gd</link>
      <description>BACKGROUND: Ensuring that clinical trial enrollment reflects the demographics and disease burden of a cancer center's catchment area is essential for improving trial accrual and the generalizability of research findings. We hypothesized that aligning the clinical trial portfolio with the needs of the catchment area can enhance enrollment and access to novel therapeutics.
METHODS: A retrospective cohort study was conducted at the University of California Irvine Chao Family Comprehensive Cancer Center (CFCCC), an National Cancer Institute-designated cancer center serving Orange County (OC), California-the 6th largest populous county in the United States. Clinical trial enrollment data from 2015 to 2023 were analyzed using the CFCCC clinical research database. Patient demographics, tumor types, and trial enrollment patterns were compared with population-level data from NIH SEER for both OC and the United States.
RESULTS: Between 2015 and 2023, 2317 participants were enrolled in clinical...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2r80c7gd</guid>
      <pubDate>Tue, 3 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Lee, Frank</name>
      </author>
      <author>
        <name>Mahadevan, Aditya</name>
        <uri>https://orcid.org/0000-0002-2834-5487</uri>
      </author>
      <author>
        <name>Azizi, Armon</name>
      </author>
      <author>
        <name>Valerin, Jennifer</name>
      </author>
      <author>
        <name>Mar, Nataliya</name>
      </author>
      <author>
        <name>Jeyakumar, Deepa</name>
        <uri>https://orcid.org/0000-0002-8822-1814</uri>
      </author>
      <author>
        <name>Dayyani, Farshid</name>
        <uri>https://orcid.org/0000-0002-4970-5189</uri>
      </author>
    </item>
    <item>
      <title>Extended-Spectrum β-Lactamase-Producing Escherichia coli and Pediatric UTIs: A Review of the Literature and Selected Experimental Observations</title>
      <link>https://escholarship.org/uc/item/6zk1w8wk</link>
      <description>Urinary tract infections (UTIs) are common in children and are predominantly caused by uropathogenic Escherichia coli (UPEC). An increasing proportion of these strains produce extended-spectrum β-lactamases (ESBLs), which render β-lactam antibiotics ineffective. Interestingly, some patients with ESBL-producing UTIs improve clinically following treatment with antibiotics like cephalexin, despite demonstrated in vitro resistance. Working alongside and at times synergistically with antibiotics, host immune factors, such as the antimicrobial peptide cathelicidin (LL-37), contribute to bacterial clearance through direct killing and inhibition of biofilm formation. In this review, we summarize the current understanding of pediatric ESBL-producing UPEC infections and present selected in vitro and in vivo experimental data evaluating the combined effects of LL-37 and cephalexin on clinical isolates. Although no synergy was observed, ESBL-producing isolates demonstrated reduced bacterial...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6zk1w8wk</guid>
      <pubDate>Wed, 28 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Tamas, Vanessa</name>
      </author>
      <author>
        <name>Ulloa, Erlinda R</name>
      </author>
      <author>
        <name>Kumaraswamy, Monika</name>
      </author>
      <author>
        <name>Dahesh, Samira</name>
      </author>
      <author>
        <name>Zurich, Raymond</name>
      </author>
      <author>
        <name>Nizet, Victor</name>
      </author>
      <author>
        <name>Coady, Alison</name>
      </author>
    </item>
    <item>
      <title>Azithromycin: An Underappreciated Quinolone-Sparing Oral Treatment for Pseudomonas aeruginosa Infections</title>
      <link>https://escholarship.org/uc/item/6md3m18f</link>
      <description>Outpatient treatment of &lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt; infections is challenged by increasing rates of resistance to fluoroquinolones, the only class of antibiotics which offers an established oral route of administration against this organism. Azithromycin does not demonstrate activity against &lt;i&gt;P. aeruginosa&lt;/i&gt; when evaluated under standard methods of susceptibility testing with bacteriologic media. However, growing evidence shows that azithromycin is very active against &lt;i&gt;P. aeruginosa&lt;/i&gt; when using physiologic media that recapitulate the in vivo milieu and is supported by animal models of infection and various clinical settings, including cystic fibrosis. We present three cases of outpatient management of &lt;i&gt;P. aeruginosa&lt;/i&gt; otolaryngological infections successfully treated with oral azithromycin, 500 mg daily ranging from 3-8 weeks, where use of fluoroquinolones was not possible due to either resistance or patient intolerance. We review the previous data supporting this...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6md3m18f</guid>
      <pubDate>Wed, 28 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Ulloa, Erlinda R</name>
      </author>
      <author>
        <name>Sakoulas, George</name>
      </author>
    </item>
    <item>
      <title>Rapid valve sterilization with meropenem plus ceftolozane/tazobactam combination therapy for Pseudomonas aeruginosa prosthetic valve endocarditis</title>
      <link>https://escholarship.org/uc/item/6gr264ss</link>
      <description>Background: &lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt; infective endocarditis (IE) presents a significant clinical challenge, leading to high rates of treatment failure and mortality. Even with the use of antipseudomonal β-lactams combined with aminoglycosides or fluoroquinolones, these therapies often fail to provide clinical resolution and are frequently accompanied by severe adverse effects.
Methods: We report a case of &lt;i&gt;P. aeruginosa&lt;/i&gt; prosthetic valve endocarditis successfully treated with a combination of meropenem and ceftolozane/tazobactam. To investigate the synergistic effects of this combination, we conducted checkerboard, time-kill, human whole blood killing, and biofilm assays, as well as a simulated endocardial vegetation (SEV) model.
Results: Meropenem plus ceftolozane/tazobactam combination therapy successfully bridged the patient to cardiac surgery, achieving rapid microbiological clearance and sterile intraoperative valve cultures. While checkerboard assays showed additivity,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6gr264ss</guid>
      <pubDate>Wed, 28 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Alaguvel, Valliammai</name>
      </author>
      <author>
        <name>Khetarpal, Anuj K</name>
      </author>
      <author>
        <name>Jankeel, Allen</name>
      </author>
      <author>
        <name>Tapia-Cano, Wendy A</name>
      </author>
      <author>
        <name>Martinez, Gabriela</name>
      </author>
      <author>
        <name>Lorenzana, Arianna</name>
      </author>
      <author>
        <name>Hsiao, Zoe</name>
      </author>
      <author>
        <name>Rose, Warren</name>
      </author>
      <author>
        <name>Sakoulas, George</name>
      </author>
      <author>
        <name>Ulloa, Erlinda R</name>
      </author>
    </item>
    <item>
      <title>Ticagrelor Increases Platelet-Mediated Staphylococcus aureus Killing, Resulting in Clearance of Bacteremia</title>
      <link>https://escholarship.org/uc/item/59w184vx</link>
      <description>Platelets are a critical immune defense against Staphylococcus aureus bloodstream infections. Staphylococcus aureus α-toxin is a virulence factor that decreases platelet viability and accelerates platelet clearance. It has been shown that ticagrelor blocks α-toxin-mediated platelet injury and resulting thrombocytopenia, protecting mice in a lethal S. aureus sepsis model. We now present the use of ticagrelor as adjunctive therapy in a patient with a S. aureus endovascular infection and thrombocytopenia, associated with restoration of platelet count and bacteremia clearance. Ticagrelor enhanced platelet killing of the S. aureus bloodstream isolate from the treated patient in vitro.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/59w184vx</guid>
      <pubDate>Wed, 28 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Ulloa, Erlinda R</name>
      </author>
      <author>
        <name>Uchiyama, Satoshi</name>
      </author>
      <author>
        <name>Gillespie, Robert</name>
      </author>
      <author>
        <name>Nizet, Victor</name>
      </author>
      <author>
        <name>Sakoulas, George</name>
      </author>
    </item>
    <item>
      <title>Overcoming Ceftaroline Resistance in MRSA Using Ceftaroline–Carbapenem Combination Therapy</title>
      <link>https://escholarship.org/uc/item/48f581zk</link>
      <description>The limited but rising threat of ceftaroline-resistant MRSA poses a therapeutic challenge. We show that ceftaroline plus carbapenems restores activity against a resistant strain both in vitro and in a murine bacteremia model. These findings support combination therapy as a potential strategy for difficult MRSA infections, warranting further clinical investigation.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/48f581zk</guid>
      <pubDate>Wed, 28 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Olson, Joshua</name>
      </author>
      <author>
        <name>Alaguvel, Valliammai</name>
      </author>
      <author>
        <name>Pérez-Parra, Gabriel</name>
      </author>
      <author>
        <name>Jankeel, Allen</name>
      </author>
      <author>
        <name>Khetarpal, Anuj K</name>
      </author>
      <author>
        <name>Rodríguez-Guevara, Valeria</name>
      </author>
      <author>
        <name>Vu, Vanessa</name>
      </author>
      <author>
        <name>Sakoulas, George</name>
      </author>
      <author>
        <name>Ulloa, Erlinda R</name>
      </author>
    </item>
    <item>
      <title>Ethylenediaminetetraacetic Acid Enhances Vancomycin and Reactive Oxygen Species–Mediated Killing of Vancomycin-Intermediate Staphylococcus aureus</title>
      <link>https://escholarship.org/uc/item/2xz0f202</link>
      <description>Background: The emergence of antibiotic-tolerant staphylococcal strains, such as vancomycin-intermediate &lt;i&gt;Staphylococcus aureus&lt;/i&gt; (VISA), poses a significant healthcare challenge and complicates treatment regimens. VISA often exhibits mutations in Krebs cycle enzymes, promoting anaerobic metabolism under physiological conditions and reducing susceptibility to antibiotics and innate immune defenses-factors not typically captured in standard susceptibility testing. Building on these findings, we investigated ethylenediaminetetraacetic acid (EDTA), a chelator that enhances reactive oxygen species (ROS) production, as an adjunct to vancomycin for combating VISA infections.
Methods: RNA sequencing analysis compared gene expression of a well-characterized VISA strain (D712) under physiological versus nutrient-rich conditions. Hydrogen peroxide (H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;) killing assays were conducted with and without the hydroxyl radical quencher thiourea, while neutrophil killing...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2xz0f202</guid>
      <pubDate>Wed, 28 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Olson, Joshua</name>
      </author>
      <author>
        <name>Khetarpal, Anuj K</name>
      </author>
      <author>
        <name>Jankeel, Allen</name>
      </author>
      <author>
        <name>Lorenzana, Arianna</name>
      </author>
      <author>
        <name>Nizet, Victor</name>
      </author>
      <author>
        <name>Sakoulas, George</name>
      </author>
      <author>
        <name>Ulloa, Erlinda R</name>
      </author>
    </item>
    <item>
      <title>Potent Activity of Ertapenem Plus Cefazolin Within Staphylococcal Biofilms: A Contributing Factor in the Treatment of Methicillin-Susceptible Staphylococcus aureus Endocarditis</title>
      <link>https://escholarship.org/uc/item/20h1r4vr</link>
      <description>Background: Besides antistaphylococcal beta-lactams and source control, there are limited validated antimicrobial salvage options in patients with prolonged methicillin-susceptible &lt;i&gt;Staphylococcus aureus&lt;/i&gt; (MSSA) bacteremia, including infective endocarditis (IE).
Methods: MSSA IE cases treated with ertapenem (ETP) plus cefazolin (CZ) were compared with matched IE cases treated with standard beta-lactam monotherapy. The bactericidal activity of ETP plus CZ was also compared with nafcillin (NAF), CZ, and ETP alone using an in vitro MSSA biofilm model.
Results: The median duration of bacteremia experienced by patients (n = 12) while on CZ or NAF was 4 days (range 1-16 days) compared with 1 day (range 1-3 days) for patients (n = 5) treated with ETP + CZ (&lt;i&gt;P&lt;/i&gt; = .01, Mann-Whitney &lt;i&gt;U&lt;/i&gt; test). Cefazolin and NAF alone or in combination did not achieve biofilm eradication at clinically relevant concentrations. However, the addition of ETP to CZ led to bactericidal eradication...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/20h1r4vr</guid>
      <pubDate>Wed, 28 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Gilbertie, Jessica</name>
      </author>
      <author>
        <name>Ulloa, Erlinda R</name>
      </author>
      <author>
        <name>Daiker, Jennifer C</name>
      </author>
      <author>
        <name>Nguyen, Khanh</name>
      </author>
      <author>
        <name>Smelter, Dan</name>
      </author>
      <author>
        <name>Rose, Warren</name>
      </author>
      <author>
        <name>Geriak, Matthew</name>
      </author>
      <author>
        <name>Schnabel, Lauren V</name>
      </author>
      <author>
        <name>Nizet, Victor</name>
      </author>
      <author>
        <name>Sakoulas, George</name>
      </author>
    </item>
    <item>
      <title>Impact of Clopidogrel on Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: a National Retrospective Cohort Study</title>
      <link>https://escholarship.org/uc/item/1zj2j4jg</link>
      <description>Activated platelets have known antimicrobial activity against Staphylococcus aureus. Accelerated clearance of platelets induced by S. aureus can result in thrombocytopenia and increased mortality in patients. Recent studies suggest that P2Y12 inhibition protects platelets from accelerated clearance. We therefore evaluated the effect of P2Y12 inhibition on clinical outcomes in patients with S. aureus bacteremia across a large national cohort. Our retrospective cohort (2010 to 2018) included patients admitted to Veterans Affairs (VA) hospitals with blood cultures positive for S. aureus and treated with standard-of-care antibiotics. Employing propensity score-matched Cox proportional hazards regression models, we compared clinical outcomes in patients treated with clopidogrel for at least the 30 days prior to admission and continuing for at least 5 days after admission to patients without any P2Y12 inhibitor use in the year preceding admission. Mortality was significantly lower among...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1zj2j4jg</guid>
      <pubDate>Wed, 28 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Caffrey, Aisling R</name>
      </author>
      <author>
        <name>Appaneal, Haley J</name>
      </author>
      <author>
        <name>LaPlante, Kerry L</name>
      </author>
      <author>
        <name>Lopes, Vrishali V</name>
      </author>
      <author>
        <name>Ulloa, Erlinda R</name>
      </author>
      <author>
        <name>Nizet, Victor</name>
      </author>
      <author>
        <name>Sakoulas, George</name>
      </author>
    </item>
    <item>
      <title>Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia</title>
      <link>https://escholarship.org/uc/item/1n58c5rc</link>
      <description>Cefazolin and ertapenem combination therapy was used successfully to salvage 11 cases (6 endocarditis) of persistent methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia, including immediate clearance (≤24 hours) in 8 cases. While in vitro synergy was modest, cefazolin plus ertapenem exhibited synergistic action in a rat model of MSSA endocarditis. The combination of cefazolin and ertapenem provides potent in vivo activity against MSSA beyond what is predicted in vitro and warrants further clinical study in the treatment of refractory MSSA bacteremia and endocarditis.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1n58c5rc</guid>
      <pubDate>Wed, 28 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Ulloa, Erlinda R</name>
      </author>
      <author>
        <name>Singh, Kavindra V</name>
      </author>
      <author>
        <name>Geriak, Matthew</name>
      </author>
      <author>
        <name>Haddad, Fadi</name>
      </author>
      <author>
        <name>Murray, Barbara E</name>
      </author>
      <author>
        <name>Nizet, Victor</name>
      </author>
      <author>
        <name>Sakoulas, George</name>
      </author>
    </item>
    <item>
      <title>Pediatric COVID-19 Health Disparities and Vaccine Equity</title>
      <link>https://escholarship.org/uc/item/18d0546n</link>
      <description>While most children with coronavirus 2019 (COVID-19) experience mild illness, some are vulnerable to severe disease and develop long-term complications. Children with disabilities, those from lower-income homes, and those from racial and ethnic minority groups are more likely to be hospitalized and to have poor outcomes following an infection. For many of these same children, a wide range of social, economic, and environmental disadvantages have made it more difficult for them to access COVID-19 vaccines. Ensuring vaccine equity in children and decreasing health disparities promotes the common good and serves society as a whole. In this article, we discuss how the pandemic has exposed long-standing injustices in historically marginalized groups and provide a summary of the research describing the disparities associated with COVID-19 infection, severity, and vaccine uptake. Last, we outline several strategies for addressing some of the issues that can give rise to vaccine inequity...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/18d0546n</guid>
      <pubDate>Wed, 28 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Oliveira, Carlos R</name>
      </author>
      <author>
        <name>Feemster, Kristen A</name>
      </author>
      <author>
        <name>Ulloa, Erlinda R</name>
      </author>
    </item>
    <item>
      <title>Gut dysbiosis and brain microhemorrhages in young vs. aged mice with chronic kidney disease</title>
      <link>https://escholarship.org/uc/item/8378j9v6</link>
      <description>Intestinal dysbiosis and gut-derived toxins in chronic kidney diseases (CKD) are associated with vascular injury. This study examined the relationship between gut dysbiosis and cerebral microhemorrhages (CMH) in young and aged CKD mice (3 vs. 16 months of age) in both sexes. CKD was induced in C57BL/6J mice using a nephrotoxic adenine diet. Serum creatinine, trimethylamine N-oxide (TMAO), indoxyl sulfate (IS) and p-cresyl sulfate (pCS) were measured. CMH was quantified via brain histology, and gut microbial sequencing was analyzed from fecal pellets. Creatinine and uremic toxins were elevated in both young and aged CKD mice compared with controls, and microbial populations were altered by age, sex and CKD status. Age was the most significant factor in microbial variance, with higher levels of IS and pCS in aged CKD mice. Aged male mice had significantly higher creatinine, TMAO and IS than aged females. Males had higher CMH counts than females, and aged CKD males had the highest...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8378j9v6</guid>
      <pubDate>Mon, 26 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Zhao, Yitong</name>
      </author>
      <author>
        <name>Tran, Tiffany</name>
      </author>
      <author>
        <name>Fang, Chuo</name>
      </author>
      <author>
        <name>Paganini-Hill, Annlia</name>
      </author>
      <author>
        <name>Dulkanchainun, Madison</name>
      </author>
      <author>
        <name>Mai, Emily</name>
      </author>
      <author>
        <name>Eprem, Lucy</name>
      </author>
      <author>
        <name>Cribbs, David</name>
      </author>
      <author>
        <name>Fisher, Mark</name>
        <uri>https://orcid.org/0000-0001-9802-8826</uri>
      </author>
      <author>
        <name>Lau, Wei Ling</name>
        <uri>https://orcid.org/0000-0002-3118-1073</uri>
      </author>
    </item>
    <item>
      <title>1179: THE VITAMIN B12 ANALOG COBINAMIDE: EFFICACY EVALUATION AS A MULTICHEMICAL AGENT ANTIDOTE</title>
      <link>https://escholarship.org/uc/item/6vt0512t</link>
      <description>1179: THE VITAMIN B12 ANALOG COBINAMIDE: EFFICACY EVALUATION AS A MULTICHEMICAL AGENT ANTIDOTE</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6vt0512t</guid>
      <pubDate>Mon, 26 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Saber, Tina</name>
      </author>
      <author>
        <name>Saidian, Mayer</name>
      </author>
      <author>
        <name>Doosty, Melina</name>
      </author>
      <author>
        <name>Mahon, Sari</name>
      </author>
      <author>
        <name>Mukai, David</name>
      </author>
      <author>
        <name>Lee, Jangwoen</name>
      </author>
      <author>
        <name>Burney, Tanya</name>
      </author>
      <author>
        <name>Boss, Gerry</name>
      </author>
      <author>
        <name>Chan, Adriano</name>
      </author>
      <author>
        <name>Bebarta, Vikhyat</name>
      </author>
      <author>
        <name>Haouzi, Philippe</name>
      </author>
      <author>
        <name>Hendry-Hofer, Tara</name>
      </author>
      <author>
        <name>Brenner, Matthew</name>
      </author>
    </item>
    <item>
      <title>Genes Encoding Multiple Modulators of the Immune Response Are Methylated in the Prostate Tumor Microenvironment of African Americans</title>
      <link>https://escholarship.org/uc/item/5db265r4</link>
      <description>&lt;b&gt;Background/Objectives&lt;/b&gt;: Prostate cancer (PCa) is diagnosed at an earlier median age, more advanced stage, and has worse clinical outcomes in African American (AA) men compared to European Americans (EA). &lt;b&gt;Methods&lt;/b&gt;: To investigate the role of aberrant DNA methylation in tumor-adjacent stroma (TAS), methyl binding domain sequencing (MBD-seq) was performed on AA (&lt;i&gt;n&lt;/i&gt; = 17) and EA (&lt;i&gt;n&lt;/i&gt; = 15) PCa patients. This was independently confirmed using the long interspersed nuclear element-1 (LINE-1) assay. Pathway analysis was performed on statistically significantly differentially methylated genes for AA and EA TAS. DNA methylation profiles of primary cultured AA and EA carcinoma-associated fibroblasts (CAFs) were compared with AA and EA TAS. AA and EA CAFs were treated with demethylating agent 5-Azacytidine (5-AzaC). &lt;b&gt;Results&lt;/b&gt;: AA TAS exhibited higher global DNA methylation than EA TAS (&lt;i&gt;p&lt;/i&gt;-value &amp;lt; 0.001). Of the 3268 differentially methylated regions identified...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5db265r4</guid>
      <pubDate>Thu, 15 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Kumar, Vinay</name>
      </author>
      <author>
        <name>Jennings, Tara Sinta Kartika</name>
      </author>
      <author>
        <name>Ueta, Lucas</name>
      </author>
      <author>
        <name>Nguyen, James</name>
      </author>
      <author>
        <name>Song, Liankun</name>
      </author>
      <author>
        <name>McClelland, Michael</name>
        <uri>https://orcid.org/0000-0003-1788-9347</uri>
      </author>
      <author>
        <name>Chu, Weiping</name>
      </author>
      <author>
        <name>Lilly, Michael</name>
      </author>
      <author>
        <name>Ittmann, Michael</name>
      </author>
      <author>
        <name>Castro, Patricia</name>
      </author>
      <author>
        <name>Kalebasty, Arash Rezazadeh</name>
      </author>
      <author>
        <name>Mercola, Dan</name>
        <uri>https://orcid.org/0000-0002-0281-9840</uri>
      </author>
      <author>
        <name>Yazdanpanah, Omid</name>
      </author>
      <author>
        <name>Zi, Xiaolin</name>
        <uri>https://orcid.org/0000-0002-5312-7158</uri>
      </author>
      <author>
        <name>Rahmatpanah, Farah</name>
      </author>
    </item>
    <item>
      <title>Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report.</title>
      <link>https://escholarship.org/uc/item/7bb7n3r6</link>
      <description>Alectinib is a second-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) that has been widely used as first-line (1L) treatment of advanced &lt;i&gt;ALK+&lt;/i&gt; non-small cell lung cancer (NSCLC) ever since its approved indication on November 17, 2017, based on the ALEX trial and its perceived well-tolerability. Lorlatinib, a third-generation ALK TKI, achieved 1L indication on March 3, 2021, but is generally associated with adverse events including weight gain in up to 44% of patients from the recent update of the CROWN study; hence its use as 1L treatment has lagged behind alectinib. Recently, alectinib has also been reported to cause significant weight gain. Incretin receptor agonists such as glucagon-like peptide-1 receptor (GLP-1) agonists semaglutide have been approved to treat obesity (body mass index [BMI] ≥ 30). Here, we report a patients case who had gained significant weight during still on-going 12-year treatment with alectinib and achieved weight loss...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7bb7n3r6</guid>
      <pubDate>Thu, 8 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Lee, Alexandria</name>
      </author>
      <author>
        <name>Park, Cathleen</name>
      </author>
      <author>
        <name>Arter, Zhaohui</name>
      </author>
      <author>
        <name>Nagasaka, Misako</name>
      </author>
      <author>
        <name>Ou, Sai-Hong</name>
      </author>
    </item>
    <item>
      <title>Health Care Expenditures and Length of Disability Across Medical Conditions</title>
      <link>https://escholarship.org/uc/item/1pj92630</link>
      <description>OBJECTIVE: To describe the relationship between the length of short-term disability (STD) and health care spending.
METHODS: Medical claims for insured US employees on STD were evaluated to describe the distribution of disability durations and health expenditures across major diagnostic categories and common medical conditions. Correlations between health expenditures and disability durations were examined.
RESULTS: The most expensive 10% of cases accounted for more than half of total health spending. The longest 10% of cases accounted for more than one-third of total disability time. Only one-third of the most expensive cases were also among the longest in duration. Disability durations were moderately correlated with medical spending and this relationship was modified by comorbid conditions and age.
CONCLUSION: Psychosocial barriers, in addition to biomedical factors, should be considered to achieve optimal functional outcomes and well-being of patients.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1pj92630</guid>
      <pubDate>Mon, 29 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Zaidel, Catherine S</name>
      </author>
      <author>
        <name>Ethiraj, Rajesh K</name>
      </author>
      <author>
        <name>Berenji, Manijeh</name>
        <uri>https://orcid.org/0000-0001-7255-8837</uri>
      </author>
      <author>
        <name>Gaspar, Fraser W</name>
      </author>
    </item>
    <item>
      <title>A Collaborative Approach in Mechanistic Music-Based Intervention and Pain Research: NCCIH Research Networks</title>
      <link>https://escholarship.org/uc/item/9gd402jq</link>
      <description>Abstract This paper describes three research networks funded by the U.S. National Center for Complementary and Integrative Health (NCCIH) and the National Endowment for the Arts (NEA). The networks seek to advance the mechanistic understanding of music-based interventions (MBIs) for pain management. The networks address critical gaps hindering MBI research, including inconsistent terminology, lack of mechanistic understanding, and insufficient objective measures. The Music4Pain Network focuses on the development of a taxonomy, a mechanistic framework, and research priorities; the ENSEMBLE Network promotes cross-disciplinary collaboration, collation of real-world data from clinical settings, and biomarker identification; and the Audio Analgesia Network emphasizes computational methods and innovative technologies to advance mechanistic research in MBIs. Together, these networks form the Music and Health Consortium, conducting collaborative research through specialized working groups,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9gd402jq</guid>
      <pubDate>Fri, 19 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Burns, Debra S</name>
      </author>
      <author>
        <name>Bradt, Joke</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
    </item>
    <item>
      <title>Neural mechanisms of declarative memory.</title>
      <link>https://escholarship.org/uc/item/8q2826bd</link>
      <description>Neural mechanisms of declarative memory.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8q2826bd</guid>
      <pubDate>Fri, 19 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Eichenbaum, H</name>
      </author>
      <author>
        <name>Dusek, J</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Young, B</name>
      </author>
      <author>
        <name>Bunsey, M</name>
      </author>
    </item>
    <item>
      <title>Relational learning with and without awareness: Transitive inference using nonverbal stimuli in humans</title>
      <link>https://escholarship.org/uc/item/83c0k4s1</link>
      <description>Learning complex relationships among items and representing them flexibly have been shown to be highly similar in function and structure to conscious forms of learning. However, it is unclear whether conscious learning is essential for the exhibition of flexibility in learning. Successful performance on the transitive inference task requires representational flexibility. Participants learned four overlapping premise pairs (A &amp;gt; B, B &amp;gt; C, C &amp;gt; D, D &amp;gt; E) that could be encoded separately or as a sequential hierarchy (A &amp;gt; B &amp;gt; C &amp;gt; D &amp;gt; E). Some participants (informed) were told prior to training that the task required an inference made from premise pairs. Other participants (uninformed) were told simply that they were to learn a series of pairs by trial and error. Testing consisted of unreinforced trials that included the nonadjacent pair, B versus D, to assess capacity for transitive inference. Not surprisingly, those in the informed condition outperformed those...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/83c0k4s1</guid>
      <pubDate>Fri, 19 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Greene, Anthony J</name>
      </author>
      <author>
        <name>Spellman, Barbara A</name>
      </author>
      <author>
        <name>Levy, William B</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Eichenbaum, Howard B</name>
      </author>
    </item>
    <item>
      <title>The use of heart rate in a driving simulator as an indicator of age-related differences in driver workload</title>
      <link>https://escholarship.org/uc/item/7js321ht</link>
      <description>The degree to which driving complexity affects cognitive performance remains an area of great interest. Older adults do not necessarily perform as well as younger adults on complex cognitive tasks alone or when combined with different driving environments. Since the next generation of older adults is expected to drive more frequently than previous cohorts, we conducted an experiment in which subjects were presented with cognitive performance tasks during simulated driving involving four levels of environmental complexity. We monitored a physiological index, heart rate, to assess task impact on workload capacity. A total of 18 active younger drivers (19-23 years old) and 17 older drivers (51-66 years old) completed different cognitive tasks including: a simulated cellular telephone conversation (easy task), two paragraphs from the Wechsler Memory Scale (easy task), segments of the Continuous Performance Task (hard task), and Multiple Interference Task (hard task). Driving performance...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7js321ht</guid>
      <pubDate>Fri, 19 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Reimer, B</name>
      </author>
      <author>
        <name>Mehler, BL</name>
      </author>
      <author>
        <name>Pohlmeyer, AE</name>
      </author>
      <author>
        <name>Coughlin, JF</name>
      </author>
      <author>
        <name>Dusek, JA</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
    </item>
    <item>
      <title>The Evaluation of a Mind/Body Intervention to Reduce Psychological Distress and Perceived Stress in College Students</title>
      <link>https://escholarship.org/uc/item/6sw5r6jw</link>
      <description>The authors examined the effect of a 6-week mind/body intervention on college students' psychological distress, anxiety, and perception of stress. One hundred twenty-eight students were randomly assigned to an experimental group (n = 63) or a waitlist control group (n = 65). The experimental group received 6 90-minute group-training sessions in the relaxation response and cognitive behavioral skills. The Symptom Checklist-90-Revised, Spielberger State-Trait Anxiety Inventory, and the Perceived Stress Scale were used to assess the students' psychological state before and after the intervention. Ninety students (70% of the initial sample) completed the postassessment measure. Significantly greater reductions in psychological distress, state anxiety, and perceived stress were found in the experimental group. This brief mind/body training may be useful as a preventive intervention for college students, according to the authors, who called for further research to determine whether...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6sw5r6jw</guid>
      <pubDate>Fri, 19 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Deckro, Gloria R</name>
      </author>
      <author>
        <name>Ballinger, Keli M</name>
      </author>
      <author>
        <name>Hoyt, Michael</name>
        <uri>https://orcid.org/0000-0003-2274-1902</uri>
      </author>
      <author>
        <name>Wilcher, Marilyn</name>
      </author>
      <author>
        <name>Dusek, Jeffery</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Myers, Patricia</name>
      </author>
      <author>
        <name>Greenberg, Beth</name>
      </author>
      <author>
        <name>Rosenthal, David S</name>
      </author>
      <author>
        <name>Benson, Herbert</name>
      </author>
    </item>
    <item>
      <title>Chapter 23 Hypertension</title>
      <link>https://escholarship.org/uc/item/54c8c58v</link>
      <description>Chapter 23 Hypertension</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/54c8c58v</guid>
      <pubDate>Fri, 19 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Plotnikoff, Gregory A</name>
      </author>
      <author>
        <name>Dusek, Jeffery</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
    </item>
    <item>
      <title>Psychological interventions and pregnancy rates. Dropouts—random or non-random?</title>
      <link>https://escholarship.org/uc/item/2c8839r9</link>
      <description>Psychological interventions and pregnancy rates. Dropouts—random or non-random?</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2c8839r9</guid>
      <pubDate>Fri, 19 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Boivin, Jacky</name>
      </author>
      <author>
        <name>Ph, D</name>
      </author>
      <author>
        <name>Verhaak, Christianne M</name>
      </author>
      <author>
        <name>A, M</name>
      </author>
    </item>
    <item>
      <title>Study of the therapeutic effects of intercessory prayer (STEP): Study design and research methods</title>
      <link>https://escholarship.org/uc/item/22v822fx</link>
      <description>BACKGROUND: The effect of intercessory prayer (IP) on outcome in cardiac cases has been evaluated previously, but results are controversial. The goals of the Study of the Therapeutic Effects of Intercessory Prayer (STEP) are to evaluate the effects of receipt of additional study IP and awareness of receipt of additional study IP on outcomes in patients undergoing coronary artery bypass graft surgery. STEP is not designed to determine whether God exists or whether God does or does not respond to IP.
METHODS: STEP is a multicenter, controlled trial of 1802 patients in 6 US hospitals, randomized to 1 of 3 groups. Two groups were informed that they may or may not receive 14 consecutive days of additional IP starting the night before coronary artery bypass graft surgery; Group 1 received IP, Group 2 did not. A third group (Group 3) was informed that they would receive additional IP and did so. Three mainstream religious sites provided daily IP for patients assigned to receive IP. At...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/22v822fx</guid>
      <pubDate>Fri, 19 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Sherwood, Jane B</name>
      </author>
      <author>
        <name>Friedman, Richard</name>
      </author>
      <author>
        <name>Myers, Patricia</name>
      </author>
      <author>
        <name>Bethea, Charles F</name>
      </author>
      <author>
        <name>Levitsky, Sidney</name>
      </author>
      <author>
        <name>Hill, Peter C</name>
      </author>
      <author>
        <name>Jain, Manoj K</name>
      </author>
      <author>
        <name>Kopecky, Stephen L</name>
      </author>
      <author>
        <name>Mueller, Paul S</name>
      </author>
      <author>
        <name>Lam, Peter</name>
      </author>
      <author>
        <name>Benson, Herbert</name>
      </author>
      <author>
        <name>Hibberd, Patricia L</name>
      </author>
    </item>
    <item>
      <title>Impact of Vitamin D Deficiency on the Productivity of a Health Care Workforce</title>
      <link>https://escholarship.org/uc/item/9th289zw</link>
      <description>OBJECTIVE: To define the relationship between vitamin D status and employee presenteeism in a large sample of health care employees.
METHODS: Prospective observation study of 10,646 employees of a Midwestern-integrated health care system who completed an on-line health risk appraisal questionnaire and were measured for 25-hydroxyvitamin D.
RESULTS: Measured differences in productivity due to presenteeism were 0.66, 0.91, and 0.75 when comparing employees above and below vitamin D levels of 20 ng/mL, 30 ng/mL, and 40 ng/mL, respectively. These productivity differences translate into potential productivity savings of 0.191%, 0.553%, and 0.625%, respectively, of total payroll costs.
CONCLUSIONS: Low vitamin D status is associated with reduced employee work productivity. Employee vitamin D assessment and replenishment may represent a low-cost, high-return program to mitigate risk factors and health conditions that drive total employer health care costs.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9th289zw</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Plotnikoff, Gregory A</name>
      </author>
      <author>
        <name>Finch, Michael D</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
    </item>
    <item>
      <title>Psychological and Biological Outcomes: Long-Term Versus Short-Term Relaxation Response Practice</title>
      <link>https://escholarship.org/uc/item/9f75t02v</link>
      <description>Psychological and Biological Outcomes: Long-Term Versus Short-Term Relaxation Response Practice</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9f75t02v</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Chang, Bei-Hung</name>
      </author>
      <author>
        <name>Benson, Herbert</name>
      </author>
      <author>
        <name>Dusek, Jeffery</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
    </item>
    <item>
      <title>Study of the Therapeutic Effects of Intercessory Prayer (STEP) in cardiac bypass patients: A multicenter randomized trial of uncertainty and certainty of receiving intercessory prayer</title>
      <link>https://escholarship.org/uc/item/9416b8sg</link>
      <description>BACKGROUND: Intercessory prayer is widely believed to influence recovery from illness, but claims of benefits are not supported by well-controlled clinical trials. Prior studies have not addressed whether prayer itself or knowledge/certainty that prayer is being provided may influence outcome. We evaluated whether (1) receiving intercessory prayer or (2) being certain of receiving intercessory prayer was associated with uncomplicated recovery after coronary artery bypass graft (CABG) surgery.
METHODS: Patients at 6 US hospitals were randomly assigned to 1 of 3 groups: 604 received intercessory prayer after being informed that they may or may not receive prayer; 597 did not receive intercessory prayer also after being informed that they may or may not receive prayer; and 601 received intercessory prayer after being informed they would receive prayer. Intercessory prayer was provided for 14 days, starting the night before CABG. The primary outcome was presence of any complication...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9416b8sg</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Benson, Herbert</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Sherwood, Jane B</name>
      </author>
      <author>
        <name>Lam, Peter</name>
      </author>
      <author>
        <name>Bethea, Charles F</name>
      </author>
      <author>
        <name>Carpenter, William</name>
      </author>
      <author>
        <name>Levitsky, Sidney</name>
      </author>
      <author>
        <name>Hill, Peter C</name>
      </author>
      <author>
        <name>Clem, Donald W</name>
      </author>
      <author>
        <name>Jain, Manoj K</name>
      </author>
      <author>
        <name>Drumel, David</name>
      </author>
      <author>
        <name>Kopecky, Stephen L</name>
      </author>
      <author>
        <name>Mueller, Paul S</name>
      </author>
      <author>
        <name>Marek, Dean</name>
      </author>
      <author>
        <name>Rollins, Sue</name>
      </author>
      <author>
        <name>Hibberd, Patricia L</name>
      </author>
    </item>
    <item>
      <title>Psychobiological Changes from Relaxation Response Elicitation: Long-Term Practitioners vs. Novices</title>
      <link>https://escholarship.org/uc/item/8zq0m7wp</link>
      <description>OBJECTIVE: The relaxation response (RR) is a physiological state that is the counterpart to the stress response. We investigate the psychological and biological effects, as well as the correlation between these two effects that are associated with short-term vs. long-term practice of techniques that elicit the RR ("RR practice").
METHODS: The study comprised both a cross sectional and an 8-week prospective design. The study sample included individuals with a long-term RR practice ("long-term practitioners" n = 28) and those with no prior RR practice experience ("novices" n = 28). The novices received 8 weeks of RR-elicitation training ("RR training") for the prospective analysis (short-term practice).
RESULTS: Long-term practitioners reported lower levels of psychological distress than the novices before they received RR training. As a result of the 8-week RR training, novices significantly reduced their psychological distress to levels comparable to that of long-term practitioners....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8zq0m7wp</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Chang, Bei-Hung</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Benson, Herbert</name>
      </author>
    </item>
    <item>
      <title>Stress reduction correlates with structural changes in the amygdala</title>
      <link>https://escholarship.org/uc/item/8qt942t6</link>
      <description>Stress has significant adverse effects on health and is a risk factor for many illnesses. Neurobiological studies have implicated the amygdala as a brain structure crucial in stress responses. Whereas hyperactive amygdala function is often observed during stress conditions, cross-sectional reports of differences in gray matter structure have been less consistent. We conducted a longitudinal MRI study to investigate the relationship between changes in perceived stress with changes in amygdala gray matter density following a stress-reduction intervention. Stressed but otherwise healthy individuals (N = 26) participated in an 8-week mindfulness-based stress reduction intervention. Perceived stress was rated on the perceived stress scale (PSS) and anatomical MR images were acquired pre- and post-intervention. PSS change was used as the predictive regressor for changes in gray matter density within the bilateral amygdalae. Following the intervention, participants reported significantly...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8qt942t6</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Hölzel, Britta K</name>
      </author>
      <author>
        <name>Carmody, James</name>
      </author>
      <author>
        <name>Evans, Karleyton C</name>
      </author>
      <author>
        <name>Hoge, Elizabeth A</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Morgan, Lucas</name>
      </author>
      <author>
        <name>Pitman, Roger K</name>
      </author>
      <author>
        <name>Lazar, Sara W</name>
      </author>
    </item>
    <item>
      <title>The relaxation response: Reducing stress and improving cognition in healthy aging adults</title>
      <link>https://escholarship.org/uc/item/7x70z029</link>
      <description>Aging adults are vulnerable to the effects of a negative emotional state. The relaxation response (RR) is a mind-body intervention that counteracts the harmful effects of stress. Previous studies with relaxation techniques have shown the non-pharmacological benefit of reducing stress and improving the memory of healthy older adults. Our pilot study evaluated whether a RR training program would decrease anxiety levels, improve attention, declarative memory performance and/or decrease salivary cortisol levels in healthy older adults. Fifteen adults participated and were randomly assigned to a RR training or control groups. Mean age was 71.3 years and mean education level was 17.9 years. Reaction time on a simple attention/psychomotor task was significantly improved (p&amp;lt;0.0025) with RR training, whereas there was no significant improvement on complex tasks of attention, verbal, or visual declarative memory tests. Self-reported state anxiety levels showed a marginally significant...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7x70z029</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Galvin, Jennifer A</name>
      </author>
      <author>
        <name>Benson, Herbert</name>
      </author>
      <author>
        <name>Deckro, Gloria R</name>
      </author>
      <author>
        <name>Fricchione, Gregory L</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
    </item>
    <item>
      <title>Relaxation response and spirituality: Pathways to improve psychological outcomes in cardiac rehabilitation</title>
      <link>https://escholarship.org/uc/item/7t7784gb</link>
      <description>OBJECTIVES: Studies have shown beneficial effects from practicing the relaxation response (RR). Various pathways for these effects have been investigated. Previous small studies suggest that spirituality might be a pathway for the health effects of the RR. In this study, we tested the hypothesis that increased spiritual well-being by eliciting the RR is one pathway resulting in improved psychological outcomes.
METHODS: This observational study included 845 outpatients who completed a 13-week mind/body Cardiac Rehabilitation Program. Patients self-reported RR practice time in a questionnaire before and after the 13-week program. Similarly, data on spiritual well-being, measured by the subscale of Spiritual Growth of the Health-Promoting Lifestyle Profile II, were collected. The psychological distress levels were measured by the Symptom Checklist-90-Revised. We tested the mediation effect of spiritual well-being using regression analyses.
RESULTS: Significant increases in RR practice...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7t7784gb</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Chang, Bei-Hung</name>
      </author>
      <author>
        <name>Casey, Aggie</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Benson, Herbert</name>
      </author>
    </item>
    <item>
      <title>Stress Management Versus Lifestyle Modification on Systolic Hypertension and Medication Elimination: A Randomized Trial</title>
      <link>https://escholarship.org/uc/item/7sx6v0mr</link>
      <description>Isolated systolic hypertension is common in the elderly, but decreasing systolic blood pressure (SBP) without lowering diastolic blood pressure (DBP) remains a therapeutic challenge. Although stress management training, in particular eliciting the relaxation response, reduces essential hypertension its efficacy in treating isolated systolic hypertension has not been evaluated. We conducted a double-blind, randomized trial comparing 8 weeks of stress management, specifically relaxation response training (61 patients), versus lifestyle modification (control, 61 patients). Inclusion criteria were &amp;gt;or=55 years, SBP 140-159 mm Hg, DBP &amp;lt;90 mm Hg, and at least two antihypertensive medications. The primary outcome measure was change in SBP after 8 weeks. Patients who achieved SBP &amp;lt;140 mm Hg and &amp;gt;or=5 mm Hg reduction in SBP were eligible for 8 additional weeks of training with supervised medication elimination. SBP decreased 9.4 (standard deviation [SD] 11.4) and 8.8 (SD 13.0)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7sx6v0mr</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Hibberd, Patricia L</name>
      </author>
      <author>
        <name>Buczynski, Beverly</name>
      </author>
      <author>
        <name>Chang, Bei-Hung</name>
      </author>
      <author>
        <name>Dusek, Kathryn C</name>
      </author>
      <author>
        <name>Johnston, Jennifer M</name>
      </author>
      <author>
        <name>Wohlhueter, Ann L</name>
      </author>
      <author>
        <name>Benson, Herbert</name>
      </author>
      <author>
        <name>Zusman, Randall M</name>
      </author>
    </item>
    <item>
      <title>The hippocampus and memory for orderly stimulus relations</title>
      <link>https://escholarship.org/uc/item/7qg552pb</link>
      <description>Human declarative memory involves a systematic organization of information that supports generalizations and inferences from acquired knowledge. This kind of memory depends on the hippocampal region in humans, but the extent to which animals also have declarative memory, and whether inferential expression of memory depends on the hippocampus in animals, remains a major challenge in cognitive neuroscience. To examine these issues, we used a test of transitive inference pioneered by Piaget to assess capacities for systematic organization of knowledge and logical inference in children. In our adaptation of the test, rats were trained on a set of four overlapping odor discrimination problems that could be encoded either separately or as a single representation of orderly relations among the odor stimuli. Normal rats learned the problems and demonstrated the relational memory organization through appropriate transitive inferences about items not presented together during training....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7qg552pb</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Eichenbaum, Howard</name>
      </author>
    </item>
    <item>
      <title>Exploring the Effectiveness of a Comprehensive Mind–Body Intervention for Medical Symptom Relief</title>
      <link>https://escholarship.org/uc/item/7f44w3mc</link>
      <description>OBJECTIVE: The objective of this study was to describe possible changes in physical and psychologic symptoms among outpatients completing a 12-week mind-body medical symptom reduction program related to chronic medical conditions.
DESIGN: The cornerstone of the program is elicitation of the relaxation response, and the curriculum also incorporates trainings on mind-body interactions, cognitive restructuring, nutrition, and physical activity. The Medical Symptom Checklist (MSCL), Health Promoting Lifestyle Profile-II (HPLP-II) and Symptom Checklist-90R (SCL-90-R) were used to assess 331 patients' physical and psychologic symptoms before and after the intervention.
RESULTS: Significant post-treatment improvements in symptom frequency occurred for 12 individual symptoms on the MSCL, all 6 of the HPLP-II subscales, and 8 of the 9 SCL-90-R subscales from pre- to post-treatment.
CONCLUSIONS: The results from this uncontrolled study suggest that a comprehensive mind-body intervention...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7f44w3mc</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Samuelson, Marlene</name>
      </author>
      <author>
        <name>Foret, Megan</name>
      </author>
      <author>
        <name>Baim, Margaret</name>
      </author>
      <author>
        <name>Lerner, Jonathan</name>
      </author>
      <author>
        <name>Fricchione, Gregory</name>
      </author>
      <author>
        <name>Benson, Herbert</name>
      </author>
      <author>
        <name>Dusek, Jeffery</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Yeung, Albert</name>
      </author>
    </item>
    <item>
      <title>Association between oxygen consumption and nitric oxide production during the relaxation response.</title>
      <link>https://escholarship.org/uc/item/72z2332d</link>
      <description>BACKGROUND: Mind/body practices that elicit the relaxation response (RR) are currently practiced by over 30% of American adults. RR elicitation reduces volumetric oxygen consumption (VO(2)) from rest and counteracts the effects of stress, although the mechanisms mediating the RR remain unknown. This study was designed to investigate whether RR elicitation is mediated by nitric oxide (NO). We developed a method to quantify depth of RR using change in VO(2) (slope) during RR elicitation. We evaluated whether depth of RR elicitation was correlated with changes in NO, as measured by percentage changes in fractional exhaled nitric oxide (F(E)NO).
MATERIAL/METHODS: We conducted a randomized, controlled trial, in which 46 subjects were randomized to either 8-weeks of RR training using audiotapes (n=34) or 8-weeks of exposure to a control condition--receiving health-education by audiotapes (n=12). Prior to randomization, VO(2) and F(E)NO were measured while subjects listened to a control...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/72z2332d</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Chang, Bei-Hung</name>
      </author>
      <author>
        <name>Zaki, Jamil</name>
      </author>
      <author>
        <name>Lazar, Sara</name>
      </author>
      <author>
        <name>Deykin, Aaron</name>
      </author>
      <author>
        <name>Stefano, George B</name>
      </author>
      <author>
        <name>Wohlhueter, Ann L</name>
      </author>
      <author>
        <name>Hibberd, Patricia L</name>
      </author>
      <author>
        <name>Benson, Herbert</name>
      </author>
    </item>
    <item>
      <title>Inpatient Pain Management</title>
      <link>https://escholarship.org/uc/item/70m6j7jr</link>
      <description>Inpatient Pain Management</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/70m6j7jr</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Finch, Michael</name>
      </author>
      <author>
        <name>Plotnikoff, Gregory</name>
      </author>
      <author>
        <name>Knutson, Lori</name>
      </author>
      <author>
        <name>Bauer, Brent</name>
      </author>
    </item>
    <item>
      <title>The Hippocampus and Transverse Patterning Guided by Olfactory Cues</title>
      <link>https://escholarship.org/uc/item/6xm007tw</link>
      <description>Normal rats and rats with hippocampal system damage were trained on a novel, olfactory version of the transverse-patterning task that involved the concurrent learning and continued performance of 3 partially ambiguous discrimination problems (A+B-, B+C-, C+A-). Animals with lesions of the fornix or perirhinal-entorhinal cortex acquired at least as rapidly as normal rats these problems presented in sequential blocks of trials involving the same stimulus pair. All groups also performed well on an initial test session when the order of stimulus pair presentations was randomized. Normal rats continued to discriminate appropriately in additional testing sessions with trials presented in random order. By contrast, both groups with hippocampal system damage performed poorly in continued random-order testing. These results extend the generality of the deficit in transverse patterning to the olfactory modality and demonstrate that the deficit is equivalent in magnitude after fornix or...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6xm007tw</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Eichenbaum, Howard</name>
      </author>
    </item>
    <item>
      <title>A Comparison of the Effect of a Low to Moderately Demanding Cognitive Task on Simulated Driving Performance and Heart Rate in Middle Aged and Young Adult Drivers</title>
      <link>https://escholarship.org/uc/item/6qj9818d</link>
      <description>The goal of this study was to assess heart rate and driving performance while middle age and younger adults engaged in a naturalistic hands free phone task that was structured to place objectively equivalent cognitive demands on all participants. Although heart rate measures have been used in evaluating driver workload, prior studies had not compared responses in middle age and younger adults. Younger and middle age subjects performed equally well on the cellular telephone task. Middle age subjects drove more slowly overall and, as a group, did not demonstrate heart rate acceleration in response to the phone conversation that was seen in younger drivers. Both age groups showed a drop in speed control during the task. Late middle age adults appear as capable as young adults of managing the additional workload of a low to moderately demanding cognitive task while driving.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6qj9818d</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Reimer, Bryan</name>
      </author>
      <author>
        <name>Mehler, Bruce</name>
      </author>
      <author>
        <name>Coughlin, Joseph F</name>
      </author>
      <author>
        <name>Wang, Ying</name>
      </author>
      <author>
        <name>D'Ambrosio, Lisa A</name>
      </author>
      <author>
        <name>Roy, Nick</name>
      </author>
      <author>
        <name>Long, Jonathon</name>
      </author>
      <author>
        <name>Bell, Avonne</name>
      </author>
      <author>
        <name>Wood, Danielle</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
    </item>
    <item>
      <title>Optimizing Patient-Reported Outcome Collection and Documentation in Medical Music Therapy: Process-Improvement Study (Preprint)</title>
      <link>https://escholarship.org/uc/item/6m041678</link>
      <description>BACKGROUND &lt;p&gt;To measure the effectiveness of nonpharmacologic interventions delivered during clinical care, investigators need to ensure robust and routine data collection without disrupting individualized patient care or adding unnecessary documentation burden.&lt;/p&gt;   OBJECTIVE &lt;p&gt;A process-improvement study was undertaken to improve documentation consistency and increase the capture of patient-reported outcomes (PROs; ie, stress, pain, anxiety, and coping) within a medical music therapy (MT) team.&lt;/p&gt;   METHODS &lt;p&gt;We used 2 Plan-Do-Study-Act (PDSA) cycles to improve documentation processes among an MT team (13.3 clinical full-time equivalent staff). Trainings focused on providing skills and resources for optimizing pre- and postsession PRO collection, specific guidelines for entering session data in the electronic health record, and opportunities for the team to provide feedback. Two comparisons of therapists’ PRO collection rates were conducted: (1) between the 6 months before...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6m041678</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Rodgers-Melnick, Samuel N</name>
      </author>
      <author>
        <name>Block, Seneca</name>
      </author>
      <author>
        <name>Rivard, Rachael L</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
    </item>
    <item>
      <title>Meditation experience is associated with increased cortical thickness</title>
      <link>https://escholarship.org/uc/item/6k6810pw</link>
      <description>Previous research indicates that long-term meditation practice is associated with altered resting electroencephalogram patterns, suggestive of long lasting changes in brain activity. We hypothesized that meditation practice might also be associated with changes in the brain's physical structure. Magnetic resonance imaging was used to assess cortical thickness in 20 participants with extensive Insight meditation experience, which involves focused attention to internal experiences. Brain regions associated with attention, interoception and sensory processing were thicker in meditation participants than matched controls, including the prefrontal cortex and right anterior insula. Between-group differences in prefrontal cortical thickness were most pronounced in older participants, suggesting that meditation might offset age-related cortical thinning. Finally, the thickness of two regions correlated with meditation experience. These data provide the first structural evidence for experience-dependent...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6k6810pw</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Lazar, Sara W</name>
      </author>
      <author>
        <name>Kerr, Catherine E</name>
      </author>
      <author>
        <name>Wasserman, Rachel H</name>
      </author>
      <author>
        <name>Gray, Jeremy R</name>
      </author>
      <author>
        <name>Greve, Douglas N</name>
      </author>
      <author>
        <name>Treadway, Michael T</name>
      </author>
      <author>
        <name>McGarvey, Metta</name>
      </author>
      <author>
        <name>Quinn, Brian T</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Benson, Herbert</name>
      </author>
      <author>
        <name>Rauch, Scott L</name>
      </author>
      <author>
        <name>Moore, Christopher I</name>
      </author>
      <author>
        <name>Fischl, Bruce</name>
      </author>
    </item>
    <item>
      <title>A Model for Integrating a Mind/Body Approach to Cardiac Rehabilitation</title>
      <link>https://escholarship.org/uc/item/6dk52383</link>
      <description>PURPOSE: Although cardiac rehabilitation programs have been shown to decrease cardiovascular risk, morbidity, and mortality, few programs have integrated a balanced mind/body approach in which patients are taught the relaxation response and utilize cognitive behavior skills for stress management, along with diet and exercise. We examined the medical and psychological outcomes of patients treated in such a cardiac rehabilitation program in a general hospital setting.
METHODS: From 1997 to 2005, outcomes were measured in 637 patients with coronary artery disease at baseline and after a 3-month program. Components of the intervention included smoking cessation, moderate aerobic exercise, nutrition counseling, relaxation response training, and cognitive/behavioral skills.
RESULTS: Men and women improved significantly with respect to medical outcomes (blood pressure, lipids, weight, exercise conditioning, frequency of symptoms of chest pain and shortness of breath) and psychological...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6dk52383</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Casey, Aggie</name>
      </author>
      <author>
        <name>Chang, Bei-Hung</name>
      </author>
      <author>
        <name>Huddleston, James</name>
      </author>
      <author>
        <name>Virani, Narmin</name>
      </author>
      <author>
        <name>Benson, Herbert</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
    </item>
    <item>
      <title>Stress and Workplace Productivity Loss in the Heart of New Ulm Project</title>
      <link>https://escholarship.org/uc/item/677333gx</link>
      <description>OBJECTIVE: The impact of stress in conjunction with lifestyle factors on workplace productivity is understudied, thus the relationship between these variables was examined.
METHODS: Negative binomial regression was used to test the cross-sectional association between stress and productivity loss in a sample of 2823 adults.
RESULTS: After body mass index adjustment, there was an interaction between stress and physical activity (β ± SE = 0.002 ± 0.001, P = 0.033). Active participants with low stress had 2% estimated productivity loss, whereas active participants with high stress had more than 11% productivity loss. Other lifestyle factors were not significant.
CONCLUSIONS: Higher stress generally predicted greater productivity loss, but this association varied. At low stress, more activity was associated with less productivity loss. At high stress, more activity was associated with more productivity loss, perhaps indicating that individuals cope by exercising more and working less.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/677333gx</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>VanWormer, Jeffrey J</name>
      </author>
      <author>
        <name>Fyfe-Johnson, Amber L</name>
      </author>
      <author>
        <name>Boucher, Jackie L</name>
      </author>
      <author>
        <name>Johnson, Pamela Jo</name>
      </author>
      <author>
        <name>Britt, Heather R</name>
      </author>
      <author>
        <name>Thygeson, N Marcus</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
    </item>
    <item>
      <title>The Impact of Integrative Medicine on Pain Management in a Tertiary Care Hospital</title>
      <link>https://escholarship.org/uc/item/5fm0d1fs</link>
      <description>BACKGROUND: Optimal inpatient pain management remains a major institutional and therapeutic challenge. Nontoxic, nonpharmacological approaches to treating pain show promise but have not been widely implemented, nor has their effectiveness been evaluated.
AIMS: To evaluate the effectiveness of an inpatient integrative medicine consult service for pain management in 6 settings across an entire tertiary care hospital.
DESIGN: Retrospective, observational study.
SETTING: Abbott Northwestern Hospital, a 629-bed tertiary-care hospital in Minneapolis, Minn, that is part of Allina Hospitals &amp;amp; Clinics.
PARTICIPANTS: Approximately 1837 patients hospitalized between January 1, 2008, and June 30, 2009.
MEASUREMENTS: Pretreatment and posttreatment pain scores on a verbal scale of 0 to 10.
RESULTS: Most patients (66%) had never previously received integrative services. Provision of integrative services had immediate and beneficial effects on pain scores. The average reduction in pain scores...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5fm0d1fs</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Finch, Michael</name>
      </author>
      <author>
        <name>Plotnikoff, Gregory</name>
      </author>
      <author>
        <name>Knutson, Lori</name>
      </author>
    </item>
    <item>
      <title>Clinical Trials of Meditation Practices in Health Care: Characteristics and Quality</title>
      <link>https://escholarship.org/uc/item/56n9z3w1</link>
      <description>OBJECTIVE: To provide a descriptive overview of the clinical trials assessing meditation practices for health care.
DESIGN: Systematic review of the literature. Comprehensive searches were conducted in 17 electronic bibliographic databases through September 2005. Other sources of potentially relevant studies included hand searches, reference tracking, contacting experts, and gray literature searches. Included studies were clinical trials with 10 or more adult participants using any meditation practice, providing quantitative data on health-related outcomes, and published in English. Two independent reviewers assessed study relevance, extracted the data, and assessed the methodological quality of the studies.
RESULTS: Four hundred clinical trials on meditation (72% described as randomized) were included in the review (publication years 1956-2005). Five broad categories of meditation practices were identified: mantra meditation, mindfulness meditation, yoga, t'ai chi, and qigong....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/56n9z3w1</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ospina, Maria B</name>
      </author>
      <author>
        <name>Bond, Kenneth</name>
      </author>
      <author>
        <name>Karkhaneh, Mohammad</name>
      </author>
      <author>
        <name>Buscemi, Nina</name>
      </author>
      <author>
        <name>Dryden, Donna M</name>
      </author>
      <author>
        <name>Barnes, Vernon</name>
      </author>
      <author>
        <name>Carlson, Linda E</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Shannahoff-Khalsa, David</name>
      </author>
    </item>
    <item>
      <title>06. Facilitating Collection of Research and Quality Data in Integrative Medicine Clinical Settings: Views from Academic, Health System and Private Clinics</title>
      <link>https://escholarship.org/uc/item/4x50g101</link>
      <description>Focus Areas: Integrative Approaches to Care The purpose of this panel discussion is to share successful efforts from a practice-based research network (PBRN) including ten integrative medicine clinics. The BraveNet PBRN includes integrative medicine clinics with academic health centers, large health systems, and a stand-alone private practice clinic. While clinical care is prioritized across all of these centers, introducing research into clinical sites oriented to providing care poses challenges that vary by clinic environment. We will highlight some of the unique issues encountered when trying to standardize data collection in sites practicing a patient-centered, whole-systems approach to healing as well as the solutions used to overcome these issues. We will present some operational solutions and data collected from the PBRN's ongoing data registry, entitled PRIMIER. The panel will engage attendees in a dialogue centering on potential for future analyses of existing results,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4x50g101</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Dolor, Rowena</name>
      </author>
      <author>
        <name>Dusek, Jeffery</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Victorson, David</name>
      </author>
      <author>
        <name>Amoils, Steve</name>
      </author>
    </item>
    <item>
      <title>Meditation Training Leads to Changes in Regional Gray Matter Concentration</title>
      <link>https://escholarship.org/uc/item/4r16x3j6</link>
      <description>Meditation Training Leads to Changes in Regional Gray Matter Concentration</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4r16x3j6</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Hoelzel, Britta</name>
      </author>
      <author>
        <name>Carmody, James</name>
      </author>
      <author>
        <name>Dusek, Jeffery</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Hoge, Elizabeth</name>
      </author>
      <author>
        <name>Lazar, Sara</name>
      </author>
      <author>
        <name>Morgan, Lucas</name>
      </author>
      <author>
        <name>Yerramsetti, Sita</name>
      </author>
    </item>
    <item>
      <title>Evaluation of a Residential Kundalini Yoga Lifestyle Pilot Program for Addiction in India</title>
      <link>https://escholarship.org/uc/item/4m0194mc</link>
      <description>Previously reported substance abuse interventions incorporating meditation and spiritual approaches are believed to provide their benefit through modulation of both psychological and pyschosocial factors. A 90-day residential group pilot treatment program for substance abuse that incorporated a comprehensive array of yoga, meditation, spiritual and mind-body techniques was conducted in Amritsar, India. Subjects showed improvements on a number of psychological self-report questionnaires including the Behavior and Symptom Identification Scale and the Quality of Recovery Index. Application of comprehensive spiritual lifestyle interventions may prove effective in treating substance abuse, particularly in populations receptive to such approaches.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4m0194mc</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Khalsa, Sat Bir S</name>
      </author>
      <author>
        <name>Khalsa, Gurucharan S</name>
      </author>
      <author>
        <name>Khalsa, Hargopal K</name>
      </author>
      <author>
        <name>Khalsa, Mukta K</name>
      </author>
    </item>
    <item>
      <title>Effects of complementary therapies on clinical outcomes in patients being treated with radiation therapy for prostate cancer</title>
      <link>https://escholarship.org/uc/item/4g83987z</link>
      <description>BACKGROUND: This pilot randomized controlled trial (RCT) examined the clinical effects of 2 complementary (CAM) therapies, relaxation response therapy (RRT) and Reiki therapy, in men being treated with external beam radiotherapy (EBRx) for prostate cancer.
METHODS: Study participants were randomly assigned to weekly RRT, Reiki therapy twice weekly, or wait-list control. Well-validated instruments measured anxiety (STAI), depression (CES-D), and quality of life in cancer patients (FACT-G) at randomization and 3 subsequent time points.
RESULTS: Fifty-four men were randomized, and 16 of 18 (89%) of RRT and 15 of 18 (83%) of Reiki patients completed the intervention protocol. No statistically significant difference was found between the RRT, Reiki, and control groups on total scores for the STAI, CES-D, or FACT-G instruments at any time point. However, at the end of the intervention, significant improvement was found on the emotional well-being subscale of the FACT-G quality of life...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4g83987z</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Beard, Clair</name>
      </author>
      <author>
        <name>Stason, William B</name>
      </author>
      <author>
        <name>Wang, Qian</name>
      </author>
      <author>
        <name>Manola, Judith</name>
      </author>
      <author>
        <name>Dean‐Clower, Elizabeth</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>DeCristofaro, Susan</name>
      </author>
      <author>
        <name>Webster, Ann</name>
      </author>
      <author>
        <name>Doherty‐Gilman, Anne M</name>
      </author>
      <author>
        <name>Rosenthal, David S</name>
      </author>
      <author>
        <name>Benson, Herbert</name>
      </author>
    </item>
    <item>
      <title>P03.11. Relaxation response intervention induces respiration and heart rate variability changes in hypertensives</title>
      <link>https://escholarship.org/uc/item/4d82x46v</link>
      <description>P03.11. Relaxation response intervention induces respiration and heart rate variability changes in hypertensives</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4d82x46v</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>McConville, T</name>
      </author>
      <author>
        <name>Dusek, K</name>
      </author>
      <author>
        <name>Dusek, J</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
    </item>
    <item>
      <title>Relaxation Response Induces Temporal Transcriptome Changes in Energy Metabolism, Insulin Secretion and Inflammatory Pathways</title>
      <link>https://escholarship.org/uc/item/41q2f3m9</link>
      <description>The relaxation response (RR) is the counterpart of the stress response. Millennia-old practices evoking the RR include meditation, yoga and repetitive prayer. Although RR elicitation is an effective therapeutic intervention that counteracts the adverse clinical effects of stress in disorders including hypertension, anxiety, insomnia and aging, the underlying molecular mechanisms that explain these clinical benefits remain undetermined. To assess rapid time-dependent (temporal) genomic changes during one session of RR practice among healthy practitioners with years of RR practice and also in novices before and after 8 weeks of RR training, we measured the transcriptome in peripheral blood prior to, immediately after, and 15 minutes after listening to an RR-eliciting or a health education CD. Both short-term and long-term practitioners evoked significant temporal gene expression changes with greater significance in the latter as compared to novices. RR practice enhanced expression...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/41q2f3m9</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Bhasin, Manoj K</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Chang, Bei-Hung</name>
      </author>
      <author>
        <name>Joseph, Marie G</name>
      </author>
      <author>
        <name>Denninger, John W</name>
      </author>
      <author>
        <name>Fricchione, Gregory L</name>
      </author>
      <author>
        <name>Benson, Herbert</name>
      </author>
      <author>
        <name>Libermann, Towia A</name>
      </author>
    </item>
    <item>
      <title>Evaluation of an 8-Week Resilience Training Program in Moderate to Severely Depressed Patients</title>
      <link>https://escholarship.org/uc/item/40h4j1b3</link>
      <description>Evaluation of an 8-Week Resilience Training Program in Moderate to Severely Depressed Patients</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/40h4j1b3</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Denton, Carolyn</name>
      </author>
      <author>
        <name>Emmons, Henry</name>
      </author>
      <author>
        <name>Knutson, Lori</name>
      </author>
      <author>
        <name>Masemer, Susan</name>
      </author>
      <author>
        <name>Plotnikoff, Gregory</name>
      </author>
    </item>
    <item>
      <title>Mind-body medicine: a model of the comparative clinical impact of the acute stress and relaxation responses.</title>
      <link>https://escholarship.org/uc/item/3vw44745</link>
      <description>Although the physiological and biochemical changes that occur during the acute stress response have been well-characterized, the contrasting changes that underlie the relaxation response evoked by various mind-body techniques are less understood. To help guide future mind-body research, we present a conceptual model that integrates patterns of change at the physiological and molecular levels. In addition, we point to future research opportunities and discuss how repeated elicitation of these responses could influence the health of patients.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3vw44745</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
      <author>
        <name>Benson, Herbert</name>
      </author>
    </item>
    <item>
      <title>Mind/body interventions for hot flashes</title>
      <link>https://escholarship.org/uc/item/3r80d0wz</link>
      <description>Mind/body interventions for hot flashes</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3r80d0wz</guid>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Kagan, Leslee</name>
      </author>
      <author>
        <name>Dusek, Jeffery A</name>
        <uri>https://orcid.org/0000-0001-9581-0564</uri>
      </author>
    </item>
  </channel>
</rss>
